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Abstract 
 
Objectives: The objective of this study was to describe the current parenteral nutrition (PN) prescription 
practices and knowledge of prescribers (paediatric doctors and dietitians) for their neonatal and paediatric 
patients, in South Africa, and to establish the factors which influence usage and adherence to the available 
guidelines. 
Methods:  A descriptive cross-sectional survey was conducted from November 2016 to March 2017 through 
a self-administered online questionnaire.  PN prescription factors were assessed in terms of timing, patient 
type and diagnosis, use of macronutrients, and fluid allocations.  Prescriber knowledge of the ESPGHAN 
international guidelines was assessed, as well as access to information.  Knowledge and practice score 
competency levels were set, a priori, at 60% and 80% respectively.  Respondents were stratified according to 
work sector (state / private) or professional group (dietitian / paediatric doctor) for statistical comparison.  
Summary statistics, chi-squared tests and correlation coefficients were used to describe and analyse the data. 
Results:  A total of 72 survey respondents were included, 58% dietitians and 42% paediatric doctors; 47% 
private sector and 53% state sector based.   
The primary indications for PN use were gut abnormalities and intolerances, prematurity and critical illness.  
Doctors prioritised fluid calculation in determining their PN prescription.  Dietitians were significantly more 
likely to calculate the patient-specific protein requirements (p < 0.001).  Only 36% of prescribers commenced 
PN feeding within the first 24 hours of admission, but the majority (67%) introduced intravenous lipid 
emulsion (IVLE) from day 1 of PN.   The main reasons given for IVLE delay were habit, liver function concerns, 
and PN bag availability. 
The mean practice score was 75% (SD ± 17).  There was no significant difference in mean score between the 
work sector subgroups (75 ± 20% state versus 76 ± 15% private; p = 0.82).  The dietitians, however, scored 
significantly higher for practice outcomes compared with the doctors (82 ± 12% versus 65 ± 19 %; p < 0.001). 
The main potential factors that influenced the delay or non-use of PN when it was indicated included 
concerns regarding infectious complications and financial resource constraints.  Inadequate access to PN, 
and a lack of trained staff to administer the PN, also impacted on its use.   
Only 64 of the respondents completed the knowledge section of the questionnaire.  The mean knowledge 
score was 74% (SD ± 12), range 50 – 100%.  There was no significant difference in mean score between the 
work sector subgroups (73 ± 13% for state versus 76 ± 12 % for private; p = 0.32).  The mean knowledge score 
for the dietitians (77 ± 13%) was however significantly higher than that of the doctors (71 ± 11%); (p = 0.04). 
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Conclusion:  PN prescribing practices in South Africa for neonatal and paediatric patients are not yet optimal 
in many respects.  Prescribers require access to clear PN therapy guidelines, as well as guidance on how to 
implement these recommendations effectively in daily clinical practice.  A multidisciplinary approach to PN 
feeding is paramount.   Our findings emphasise the role of the dietitian as part of the multidisciplinary team 
in achieving optimal feeding.  Additional research is warranted to further assess the PN feeding practices in 
this vulnerable patient group.   
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Opsomming 
 
Doelwitte: Die doel van hierdie studie was om pediatriese dokters en dieetkundiges se huidige 
voorskrifpraktyke en kennis van parenterale voeding (PV) vir neonatale en pediatriese pasiënte in Suid-Afrika 
te bepaal; asook die faktore wat die gebruik en nakoming van beskikbare riglyne beïnvloed vas te stel. 
Metodes:  ‘n Dwarssnit beskrywende studie is uitgevoer vanaf November 2016 – Maart 2017 deur middel 
van ‘n self-geadministeerde aanlyn vraelys. Faktore wat PV voorskrifte beïnvloed soos tyd geïnisieer, pasiënt 
tipe en diagnose, gebruik van makronutriënte en vloeistofbehoeftes is bepaal. Kennis van die ESPGHAN 
internasionale riglyne en toegang tot inligting is bepaal onder die voorskrywers. Die vaardigheidsvlakke vir 
kennis en praktyke is onderskeidelik vooraf vasgestel op 60% en 80%. Vir statistiese vergelykings is 
respondente stratifiseer volgens werksektor (staat / privaat) en professionale groep (dieetkundiges / 
pediatriese dokters). Beskywende statistiek, chi-kwadraat toetse en korrelasie koëfisiente is gebruik om data 
te beskryf en analiseer.  
Results:  ‘n Totaal van 72 respondente is ingesluit, 58% dieetkundiges en 42% pediatriese dokters; 47% 
private sektor en 53% staatssektor gebasseer.  
Die hoof indikasies vir PV gebruik was dermkanaal abnormaliteite en intoleransies, prematuriteit en kritieke 
siekte. Dokters het vloeistof berekeninge geprioriseer in die berekening van hul PV voorskrifte. Dieetkundiges 
was beduidend meer geneig om pasiënt-spesifieke proteïen behoeftes te bereken (p < 0.001). Slegs 36% van 
respondente het PV beginbinne die eerste 24 uur na toelating. Die meerderheid (67%) het egter intraveneuse 
lipied emulsies begin op dag 1 van PV. Die hoofredes verskaf vir die vertraging van lipied toediening was 
gewoonte, lewerfunksie bekommernisse en beskikbaarheid van die PV sakke.  
Die gemiddelde praktyktelling was 75% (SD ±17). Daar was geen beduidende verskil in die gemiddelde telling 
tussen werksektor subgroepe (75±20% staat versus 76±15% privaat; p= 0.82). Die dieetkundiges het egter 
beduidende hoër tellings verkry teenoor die dokters (82 ± 12% versus 65 ± 19 %; p < 0.001). 
Bekommernisse oor infektiewe komplikasies en finansiële beperkings was die hoof potensiële faktor vir die 
vertraging of nie-gebruik van PV in gevalle waar dit aangedui was. Onvoldoende toegang tot PV en ‘n tekort 
aan opgeleide personeel om PV te kan toedien het ook die gebruik beïnvloed. 
Slegs 64 van die respondente het die kennisdeel van die vraelys voltooi. Die gemiddelde kennistelling van 
74% (SD±12), reikwydte 50-100%. Daar was geen beduidende verskil in die gemiddelde telling tussen 
werksektor subgroepe nie (73 ± 13% staat versus 76 ± 12 % privaat; p = 0.32). Die gemiddelde kennistelling 
van die dieetkundiges (77 ± 13%) was egter beduidend hoër as die van die dokters (71 ± 11%); (p = 0.04). 
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Gevolgtrekking:  PV voorskrifpraktyke in Suid-Afrikavir neonatale en pediatriese pasiënte is nie optimaal in 
baie aspekte. Diegene wat PV voorskryf benodig toegang tot duidelike PV terapeutiese riglyne, asook 
raadgewing oor hoe om die riglyne effektief te implementeer in daaglikse kliniese praktyke. ‘n 
Multidissiplinêre benadering tot PV praktyk is noodsaaklik. Ons bevindinge het die rol van die dieetkundige 
om optimale voeding te bereik as deel van die multidissiplinêre span beklemtoon. Addisionele navorsing is 
nodig om die PV voedingpraktyke van hierdie kwesbare pasiëntgroep te bepaal. 
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Chapter 1: Literature Review 
 
1.1 Introduction 
 
Parenteral nutrition (PN) is indicated for the provision of nutrients to neonatal and paediatric patients when 
it is not possible to feed adequately, or at all, into the gastrointestinal tract.1–4 This patient population has 
high nutritional requirements, both in terms of protein and energy, as well as micronutrients, owing to their 
ongoing growth and development.  In the context of their high nutritional demands, and relatively limited 
reserves, inadequate feeding during hospitalisation can have a significant influence on both their short- and 
long-term clinical outcomes.1–3,5–7 
 
Owing to a paucity of standardised recommendations, many decisions related to feeding in this patient 
population are based on clinical knowledge and experience.  The only detailed guidelines to date are those 
published in 2005 by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition 
(ESPGHAN).8 The successful implementation of these guidelines in actual clinical practice is however fraught 
with challenges – the vulnerability and complexity of the patient group, the wide variations in PN solutions 
and availability, the role of the multidisciplinary team, and the setting and context are just a few 
considerations.7,9–13  Research investigating actual clinical practice in terms of the understanding and 
implementation of these PN guidelines is also still quite limited.10–12 
 
In many hospitals worldwide, PN is compounded on a patient-specific basis at hospital level. Fresenius Kabi 
is currently the sole supplier of neonatal and paediatric PN in South Africa, and all the available components 
are therefore their registered single units.  These single units are combined into standardised formulations 
at a commercial compounding facility before distribution to hospitals.  It is evident from a review of the 
current literature that the provision of all-in-one standardised PN bags to both neonatal and paediatric 
patients is unique to the South African context, and is only now being considered and piloted in other sites 
around the world.14–16  The use of standardised bags has in a sense simplified and streamlined the process of 
prescribing PN, but no data yet exists detailing the knowledge and actual practices of PN usage for neonatal 
and paediatric patients within this context.  
 
1.2 Nutritional risk in critically ill infants and children 
 
Premature neonates, and critically ill infants and children, are a unique patient population in terms of their 
needs for medical management, including nutritional support.  Their high nutrient demands due to ongoing 
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growth and development, in conjunction with relatively limited energy reserves, place them at high risk of 
developing malnutrition during hospitalisation.1,2,17  The incidence of malnutrition in this group varies 
between 25% and 70%.1  Nutrient deficits may negatively impact recovery, but more importantly result in 
growth faltering and long-term developmental delays.  Malnutrition may also contribute to prolonged 
hospitalisation and elevated health costs.1,2,7,17 
 
Premature infants are a particularly high-risk group and present the additional feeding challenge of 
attempting to mimic inter-uterine growth and maintain anabolism at foetal rates, as well as achieve a 
functional outcome similar to that of an infant born at term.  The balance between the energy provision and 
amino acid supply also appears to be important as caloric intake may influence protein accretion. Postnatal 
growth restriction is a powerful predictor of long-term morbidity and poor neurodevelopmental outcomes 
in this patient group.3,4,6,7,18,19  Stephens et al. (2009) determined that optimising protein and energy intakes 
within the first week of life in extreme low birth weight (ELBW) infants affected both length growth and the 
Mental Development Index (MDI) scores at 18 months of corrected age.  An increase in calories by 10 kCal/kg 
per day was independently associated with a 4.6-point increase in the MDI and an additional 1 g/kg per day 
of protein by a noteworthy 8.2-point MDI increase.20  Yang et al. (2015) demonstrated similar results in their 
retrospective cohort study of very low birth weight (VLBW) infants – a positive correlation between amino 
acid provision and neurodevelopmental outcomes at the age of 2 years.18  The Standardised, Concentrated, 
Additional Micronutrients, Parenteral (SCAMP) nutrition study was a randomised trial that investigated 
postnatal head growth (as an indicator of brain growth and later neurodevelopmental outcome), and showed 
that early, aggressive nutritional intervention in this patient group can improve outcomes.6,21 
 
It is therefore well established in the literature that achieving optimal growth targets as well as long-term 
developmental outcomes is the ultimate goal of nutrition therapy in premature, and critically ill infants and 
children.  The type and duration of nutrition therapy will vary in each clinical scenario, but PN definitely plays 
a role in improving the realisation of this goal. 
 
1.3 Indications for parenteral nutrition 
 
PN can be considered an effective yet invasive, and relatively expensive intervention, and as such will always 
be a secondary choice to commencing with enteral feeding.  Enteral nutrition (EN) remains the preferred 
method of nutritional support for all premature infants, and paediatric patients.1,3,4,7  Unfortunately, gut 
tolerance and physiological and clinical complications are often limiting factors in feeding solely via the 
enteral route, and supplementary or complete PN is necessary to avoid poor growth and medical 
outcomes.3,8,9  Guidelines vary, but most appear to agree that in premature infants where no significant 
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enteral feeds can be established within 3 days, that starting early with parenteral feeding is important.  In 
fact, in the ELBW and VLBW neonates, it is beneficial to start PN within 2–6 hours of birth in order to 
successfully mimic inter-uterine growth conditions.3,7–9,22 In older children, depending on their diagnosis and 
nutritional status, the commencement of PN can be delayed for up to 7 days.  As with adults, if the patient 
presents on admission with malnutrition, particularly underweight or wasting, the introduction of PN more 
immediately is advisable.23  The most common indication for PN therapy in paediatric patients is in instances 
of gut failure and enteral feeding intolerance.  Patients with particularly high nutritional requirements, such 
as those admitted with burns and trauma injuries, may rely on supplementary PN to meet these elevated 
needs.  Many patients with chronic diagnoses, such as those in oncology, renal, and even cardiac units, are 
at high risk of malnutrition, and may require PN to meet their high nutrient requirements and combat this 
malnutrition, as well as enable the provision of optimal nutrition in often limited fluid allowances.1,8,9,24   Table 
1.1 provides a summary of the indications for PN use in children.9  
 
TABLE 1.1 INDICATIONS FOR PARENTERAL NUTRITION IN CHILDREN 
Gut failure Other common indications 
Patients requiring aggressive 
nutritional support 
Short bowel syndrome 
Preterm infants – functional 
immaturity  
Trauma 
Necrotising enterocolitis (NEC) 
Chemotherapy (resulting in 
acute damage to the gut) 
Burns 
Intestinal obstruction Pancreatitis 
Chronic kidney disease 
Ischaemia or inflammation of 
the gastrointestinal tract 
Chronic aspiration due to 
gastro-oesophageal reflux 
Liver disease 
Gastrointestinal haemorrhage  
Cancer 
Malabsorption syndromes  
Cystic fibrosis 
Protracted diarrhoea  
 
Peritonitis  
 
Paralytic ileus   
Inflammatory bowel disease   
  Source: Adapted from [9] 
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1.4 Available guidelines for parenteral nutrition 
 
The only international guidelines readily available for the prescription of parenteral nutrition in this patient 
group are those published in 2005 by ESPGHAN.8  There was an intention to revise the guidelines in 2016; 
however these are not available as yet.  The American Society for Parenteral and Enteral Nutrition (ASPEN) 
also has a brief mention of its recommendations as part of a publication detailing guidelines for both EN and 
PN therapy in adults and paediatric patients.25  This ASPEN paper is however outdated, and lacks the depth 
and information required to be clearly applied in clinical practice.  An updated version of the ASPEN clinical 
nutrition guidelines for critically ill patients was published in 2016 but is targeted at the adult population (≥ 
18 years of age), and is therefore not applicable as a reference guideline to this study.24  ASPEN has also 
recently published paediatric-specific guidelines for both PN and EN feeding, but overall the 
recommendations are quite vague and the evidence grading low.  These guidelines do not include neonatal 
patients, focusing on 1 month to 18 years of age.23  
The paucity of relevant guidelines does lend itself to wide variations in clinical practice and the absence of 
standard principles of care worldwide.  As a result, many healthcare professionals rely on their clinical 
knowledge and experience, and their own interpretations of the literature, in their daily practice.  There are 
also many opinion papers that tend to refer to the ESPGHAN guidelines, but also highlight the challenges in 
adhering to the recommendations in a real clinical setting, and although evidence based in most cases, can 
be subjective and heavily influenced by context.4,9,26–29  With the influence of context in mind, it is useful for 
the purposes of this research to refer to a South African-based review by Velaphi (2011), “Nutritional 
requirements and parenteral nutrition in preterm infants”, in addition to the ESPGHAN guidelines.29  
 
1.5 Nutrient requirements and available parenteral nutrition components 
 
1.5.1 Fluid and electrolytes 
 
As much as protein and calories are the focus in terms of meeting growth and development goals in neonatal 
and paediatric patients, it is appropriate to first discuss fluid requirements and management.  In many 
instances, it is the fluid allowance that dominates the feeding decisions and achievements.  PN is often not 
given priority when fluid needs to be restricted, which makes optimal feeding a challenge.  Also, the amount 
of each of the nutrients that can practically be included in a stable solution is also often limited by the amount 
of fluid.8,9,26,30  
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In preterm and neonatal patients, it is important to be aware of the various phases of insensible water loss, 
and how these will influence the fluid management, and therefore PN administration.  The first week consists 
of a transition phase, followed by a stabilisation phase as the body adapts to life outside the womb.  Finally, 
in the second week of life, the stable growth phase begins, and marks the turning point in terms of positive 
fluid and electrolyte balance and weight gain.  In the first week, the patient is particularly vulnerable to fluid 
overload and this may influence the amount of PN given.8,9,26,30 
Fluid and electrolyte therapy is influenced by multiple factors – the age, weight, clinical condition and 
treatment of the patient all contribute.  Table 1.2 presents a summary of a guideline for the requirements in 
neonatal and paediatric patients.8,9 It should be noted that this is only a guideline, and that owing to the 
complexity of influences on fluid and electrolytes, the key message in the literature is the importance of an 
individualised approach.  The administration of optimal feeding with PN within the context of overall fluid 
goals necessitates discussion between members of the multidisciplinary team to ensure that nutritional goals 
are not compromised at the expense of fluid goals and vice versa.8,9,26  
 
TABLE 1.2 SUMMARY OF DAILY PARENTERAL FLUID AND ELECTROLYTE REQUIREMENTS 
Age/Weight Fluid  
(mL/kg/d) 
Na+  
(mmol/kg/d) 
K+  
(mmol/kg/d) 
<1500g 140 – 180 2.0 – 3.0 1.0 – 2.0 
>1500g 140 – 160 3.0 – 5.0 1.0 – 3.0 
Preterm to 2 months 140 – 160 2.0 – 5.0 1.5 – 5.0 
2 months to 1 yr 120 – 180 2.0 – 3.0 1.0 – 3.0 
1 – 2 years 80 – 150 1.0 – 3.0 1.0 – 3.0 
3 – 5 years 80 – 100 1.0 – 3.0 1.0 – 3.0 
6 – 12 years 60 – 80 1.0 – 3.0 1.0 – 3.0 
13 – 18 years 50 – 70 1.0 – 3.0 1.0 – 3.0 
  Source: Adapted from [8; 9] 
 
1.5.2 Macronutrients 
 
The ESPGHAN guidelines provide detail regarding the determination of, and factors contributing to, energy 
requirements for neonatal and paediatric patients.8  As a general rule the energy requirements for parenteral 
feeding are 10% lower than those of enteral feeding owing to the elimination of energy required for the 
process of diet-induced thermogenesis.  The life stage and therefore growth velocity, as well as baseline 
nutritional status and activity levels of the patient, are important contributing factors when calculating 
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energy requirements.  The reason for hospitalisation also needs special consideration, as prematurity, critical 
illness, and more specific diagnoses such as burns or head injury, will certainly contribute to elevated energy 
needs.8,9 
All the macronutrients are sources of energy in parenteral feeding.  It is however important to differentiate 
between the protein and non-protein (lipid and carbohydrate) energy, as the amino acids are essential for 
growth and recovery, and should not be considered for their energy contribution to feeding.  In spite of this, 
most current guidelines for energy calculations in paediatric patients seem to refer to total energy (TE).  Table 
1.3 summarises the current recommended daily intake of PN macronutrients.  Given the complex age and 
weight categories, implementing and adhering to these recommendations can prove challenging.8,9,29 
 
TABLE 1.3 SUMMARY OF DAILY PARENTERAL MACRONUTRIENT REQUIREMENTS 
Energy (TE) Amino Acids Lipids Carbohydrate 
Age (yr) kcal/kg Age g/kg Age g/kg Weight (kg) g/kg 
Preterm 110–120 Preterm 1.5–4.0 Preterm 3–4 Up to 3 10–18 
0–1 90–100 Term neonates 1.5–3.0 0–12 
months 
3–4 3–10 16–18  
1–7 75–90 2 months to 3 
years 
1.0–2.5 1–18 years 2–3 10–15 12–14 
7–12 60–75 3–18 years 1.0–2.0   15–20 10–12 
12–18 30–60     20–30 < 12 
      > 30 < 10 
  Source: Adapted from [8; 9; 29] 
 
The next section describes the current evidence base for the provision of the different macronutrients, and 
the types of solutions available in the South African PN formulations.  The ingredients used in the 
compounded bags in this country are discussed for the age range of 0 – 12 years.  Children aged 12 – 18 years 
have nutrient requirements more similar to the adult guidelines, and the standardised formulations for adults 
are therefore used for parenteral nutrition therapy in this group. 
 
1.5.2.1 Amino acids 
 
The provision of protein in the form of amino acids is often discussed in terms of nitrogen balance in a 
parenterally fed patient.  Achieving a positive nitrogen balance requires providing a minimum daily amount 
(see Table 1.3 for age-specific values), and usually equates to the provision of 10 – 20% of total energy from 
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protein.  The amino acid solution needs to contain both essential and non-essential amino acids.8,9,29  Certain 
amino acids, such as cysteine, tyrosine and taurine, are considered conditionally essential in children owing 
to their increased growth demands.  Also, owing to immaturity of some metabolic functions, it is necessary 
for certain levels of amino acids, such as methionine and phenylalanine, to be reduced in paediatric PN 
solutions to prevent toxicity.8,31  In order to achieve the goal of protein accretion and therefore growth, it is 
important to provide an optimal protein to calorie ratio.3,8,9,31    
A Cochrane Review of parenteral amino acid provision in premature infants considered the timing of amino 
acid provision – early versus late – and concluded that there was insufficient evidence to support the benefit 
of providing amino acids within the first 24 hours of birth.  Although a positive nitrogen balance was achieved 
in the earlier group, the clinical relevance of this finding could not be determined.32  In spite of this, the 
ESPGHAN guidelines, and most of the opinion papers and reviews, clearly recommend administering a 
minimum of 1.5g/kg/day within the first day of life in premature infants.4,8,33  Particularly in the ELBW and 
VLBW premature infants, there seems to be a good body of evidence to support the provision of amino acids 
as soon as possible, and that this does improve growth outcomes and potentially neurological development 
in the longer term.3,6,8,9,19,20,29,31,32  Interestingly, there is also increasing evidence that early, aggressive amino 
acid administration can be initiated without risking metabolic complications and acidosis, even in critical 
patients – the suggestion seems to be achieving at least 3g/kg/day within the first week of life, and thereby 
more readily mimicking foetal protein accretion rates.  Furthermore, commencing amino acid infusion 
immediately post birth (within 4–6 hours), is associated with improved electrolyte balance and blood glucose 
control.21,28,34 
There is a relative paucity of data for the quantity and timing of protein administration in older children (ages 
1–18 years) and much of the ESPGHAN recommendations in this group are graded C or D.8  Like in adults, 
critical illness and surgery result in increased protein catabolism, which may lead to muscle wasting and 
growth failure if the high protein requirements in the recovery phase are not met.1  Fivez et al. (2016) 
conducted a randomised clinical control trial comparing early initiation of PN therapy (within 24 hours of 
admission) in children, newborn to 17 years of age, with waiting for one week, and only commencing PN on 
day 8.  Their conclusion was that starting later was clinically superior, as this patient group had fewer new 
infections, a shorter reliance on intensive care interventions, and a shorter hospital stay.35  These results 
should however be interpreted with caution and cannot as yet be applied as a universal guideline.  Each ill 
child’s need for PN should be individually assessed by an experienced multidisciplinary team, and appropriate 
feeding interventions should be initiated as necessary.  The study population focused on critically ill children, 
and the inclusion criteria were quite broad – it is possible that some patients did not require PN intervention 
and therefore did not show clear benefit as such from the therapy.  Also, only 10% of the study participants 
were classified as high nutritional risk.  The vast age range of the study subjects also makes applying a broad 
recommendation difficult.8,26,35      
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The type and quality of amino acids provided in PN are important.  Much of the evidence for inclusion of 
certain conditionally essential amino acids is based on their upregulation in breastmilk and focused on the 
neonatal period.9  Owing to the complexity of amino acid interactions and conversions in the body, it is 
difficult to draw definitive conclusions.  The focus on the provision of a balanced, high-quality amino acid 
solution seems to be more important than individual amino acids at this stage.  Blood monitoring of individual 
amino acids is not routinely performed, and currently available amino acid formulations are based on 
relatively outdated data, and perhaps assumptions based on the physiological role of certain amino acids to 
determine need.8,9,21,36  The pharmacological stability of individual nutrients also contributes to what can 
feasibly be included in a solution.37  The role and inclusion of certain amino acids, such as glutamine and 
arginine, also still need to be more thoroughly investigated in terms of parenteral administration in neonatal 
and paediatric patients.  Currently, Aminoven® Infant 10% is the only amino acid solution available for PN 
use in neonatal and paediatric patients in South Africa.38 
 
1.5.2.2 Lipids 
 
Lipid contributes largely to  patient energy intake during parenteral feeding, and should contribute to 25 – 
40% of the non-protein calories.8  It provides energy density, thereby allowing greater energy provision in a 
smaller volume – this is particularly important in neonates and paediatric patients, where fluid restrictions 
often limit the optimal provision of nutrients.26  Lipid is also necessary to prevent the development of an 
essential fatty acid (EFA) deficiency, which can arise within 72 hours post birth in preterm infants.  The 
provision of 0.5 – 1 g/kg/day of an intravenous lipid emulsion (IVLE) appears to be sufficient to prevent 
deficiency risk.8,28,29,39  IVLE also enables the peripheral administration of PN admixtures as well as being 
important as the carrier medium for the provision of fat-soluble vitamins.8   
Table 1.3 provides the goal ranges for lipid infusion based on patient age.8,9,29  An IVLE tolerance of 3g/kg/day 
via a continuous infusion (over 24 hours), is well established in the literature, although special consideration 
needs to be given in ELBW infants and patients presenting with hyperlipidaemias.  There have been concerns 
about lipid administration in the first few days of PN infusion, mainly owing to pulmonary function 
(particularly in ELBW infants and patients with acute lung injury or chronic lung disease), but evidence is 
inconclusive and current administration levels of IVLE do not appear to affect lung function significantly.  
Some clinicians will still choose to delay lipid administration, but the guidelines state that commencing on 
day 1 is safe, and that due to EFA deficiency risk, should not be commenced later than day 3.4,8,26–30,40  It is 
also considered safe to administer IVLE in jaundiced infants – concerns have been linked to lipid infusions 
elevating the plasma free fatty acids, which may displace bilirubin from albumin binding sites, but at 
recommended administration dosages, free bilirubin does not seem to be affected.40       
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Plasma triglyceride levels should be regularly monitored in patients receiving PN, and a reduction in IVLE 
infusion should be implemented if levels exceed 250 mg/dl (2.83 mmol/L) in infants, or 400 mg/dl (4.52 
mmol/L) in older children.8,40 
There are currently two lipid emulsions available in South Africa for parenteral administration in neonates 
and paediatric patients.  Intralipid® 20%, a soybean emulsion, is most commonly used, as it is more readily 
available, and forms the standard IVLE in the available admixtures.41  A newer IVLE known as SMOF lipid® 
20%, which comprises a combination of soybean, medium-chain triglycerides (MCTs), olive oil and fish oil is 
only available on special request, so its usage is limited.42  The use of SMOFlipid® 20% in preterm and 
paediatric patients, particularly those receiving long-term PN, is well documented in the literature and 
appears to offer clinical benefit in terms of liver integrity and function, as well as reduced incidence of sepsis.  
The main benefit seems attributable to the fish oil which provides docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA), and is known to have immune-modulatory and anti-inflammatory 
chracteristics.8,9,26,40,43–47  The role of long-chain polyunsaturated fatty acids (LC-PUFAs), like DHA and EPA, 
has been widely researched in the neonatal and paediatric population owing to their high content observed 
in breastmilk.  The main demonstrable benefits link to their presence in the neural tissues, and the associated 
cognitive and developmental advantage that is achieved through regular dietary availability.  The potential 
benefits of DHA in visual function and development, as well as allergy risk reduction, have also been 
investigated, although the outcomes are less conclusive to date.  Much of the research on LC-PUFAs has 
involved human breastmilk and supplemented infant formulae, and also focuses on early infancy, but it is an 
interesting consideration for the inclusion of fish oil in PN formulations.9,48 
 
1.5.2.3 Carbohydrates 
 
Carbohydrates are the major source of non-protein energy in PN therapy, accounting for 60 – 75% of non-
protein calories, and are provided in the form of dextrose (D-glucose).8  The administration of glucose needs 
to be carefully monitored due to the risks associated with excessive intravenous (IV) infusion – this is defined 
as the provision of glucose above the threshold oxidation capability of the body.  ESPGHAN classifies the 
maximal glucose oxidation rate in premature infants as 8.3 mg/kg per minute, and recommends that in 
critically ill children, the glucose infusion should not exceed 5 mg/kg per minute.8  Some of the documented 
concerns relating to hyperglycaemia (blood plasma glucose > 10 mmol/L or 180 mg/dL) include elevated 
sepsis risk, liver steatosis and the development of cholestasis, as well as potentially elevated carbon dioxide 
levels and minute ventilation.8,26,29,49  The excessive provision of calories in the form of glucose has also been 
shown to impair protein metabolism, which could affect growth and development in this patient population.  
Prolonged hyperglycaemia suppresses the release of insulin, which is required for the effective uptake of 
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both glucose and amino acids into the cells.  Insulin is an anabolic hormone, and as such promotes growth, 
which is fundamental in neonatal and paediatric patients.50,51  The association between hyperglycaemia and 
increased infectious mortality is well documented in adult patients, and although it appears to be similar in 
paediatric patients, the studies are less conclusive to date.8,50,51  
Velaphi (2011) provided guidelines to commence glucose infusion at the hepatic glucose production rate of 
6–8 mg/kg/minute.  This can be increased in increments of 0.5–1 mg/kg/minute based on tolerance until the 
maximum glucose rate of between 12–13 mg/kg/minute is achieved.  Tolerance is largely based on blood 
glucose level monitoring, and the goal is to maintain a level between 2.5 and 8.0 mmol/L (80 and 120 mg/dL), 
avoiding the risk of hypo- or hyperglycaemia.8,28,29    
The use of insulin therapy in infants and children is less common than in adults, as exogenous insulin supply 
may inhibit protein synthesis and thereby affect growth outcomes.  There appears to be a lack of consensus 
in terms of clinical practice in this regard.4,8,9  It is important to adapt IV glucose provision based on each 
clinical situation – unstable, or critically ill patients, as well as those at risk of refeeding syndrome may need 
to start at lower rates.  It is also vitally important to include non-nutritive glucose supply in total energy 
provision to avoid hyperglycaemia and overfeeding.8,9,29,30  A South African-based study in adult critically ill 
patients showed that an average of 8% (range 0–29%) of the total energy intake can be attributed to non-
nutritional energy sources such as carbohydrate-containing IV fluids.52  Neonatalyte, a commonly used IV 
fluid, contains 10% dextrose.53  
The current PN formulations in South Africa provide glucose at a 5 or 10% concentration so that glucose 
intolerance can be accommodated to a certain extent.   
 
1.5.3 Micronutrients 
 
Micronutrients, although required in comparatively small amounts, are fundamental as co-enzymes and for 
hormone production in the body, which in turn contribute significantly to normal growth and development.  
Meeting micronutrient requirements in neonatal and paediatric PN is however complex, owing to a lack of 
clear evidence on what these exact requirements may be, as well as the challenges in terms of practically 
including them in the compounded admixtures.8,9,30,54  
There is a relative paucity of data on parenteral vitamin and mineral requirements for neonatal and paediatric 
patients.  Very little new research has been done in the last 20 years, and current administration appears to 
be based on what is available in a certain country or context, and also on historical clinical practice and expert 
opinion.  The absence of deficiency, determined by the blood levels, and also by the lack of clinical signs and 
symptoms, has led to the assumption that what is currently provided is sufficient.8,9,30,54  In fact, some 
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publications were based on shortages or absence of a certain micronutrient for parenteral use, and the 
consequent deficiencies and complications that arose in patients, and these provide evidence for their 
inclusion in PN solutions.55,56 
   
1.5.3.1 Vitamins 
 
There does appear to be consensus that both water- and fat-soluble vitamins should be provided as part of 
the PN admixture, preferably on a daily basis.  Vitamins are susceptible to instability, and it is recommended 
that whenever possible the vitamin preparations should be added to the lipid emulsion component to 
facilitate stability in the PN.  Another important factor is exposure to direct sunlight, so this should be avoided 
in order to preserve the vitamin content of the solution.8,9,30,57 
In South Africa, vitamins and minerals are currently included in all parenteral admixtures administered to 
neonatal and paediatric patients.  They are provided by Soluvit® Novum and Vitalipid Novum Infant® at the 
registered dose of 1 mL/kg/day.58,59  The inclusion in a commercially prepared all-in-one preparation inhibits 
the manipulation of the individual micronutrients.  Table 1.4 summarises the current ESPGHAN 
recommendations, based on expert opinion, in comparison with what is provided by the available vitamin 
preparations.  In some instances, the PN is providing significantly more than recommendations, but it should 
be noted that as documented in the literature, this has not been associated with any adverse effects to 
date.8,30,58,59  
In paediatric oncology patients, the provision of additional vitamins over and above the recommended 
nutrition intake (RNI) is not currently recommended.  Similarly, in burns patients, although the metabolic 
demand for certain vitamins and minerals may be increased, as demonstrated in adult studies, routine 
additional supplementation is not advised.60,61 
 
1.5.3.2 Minerals and trace elements 
 
Calcium, phosphorous and magnesium are fundamental for optimal growth and development, particularly in 
terms of bone mineralisation, but provision in PN is often limited by potential solubility issues.  Studies to 
test compatibility of parenteral nutrients in solution, in the hope of being able to increase the concentration 
of calcium in compounded admixtures, have shown no advantage over newer lipid emulsions like SMOF 
Lipid® or increasing the glucose concentration in an attempt to prevent precipitation.8,9,62,63  In South Africa, 
calcium and magnesium are presently included in the standard commercially prepared solutions in the form 
of calcium gluconate 10% and calcium chloride 10%.  Phosphorous is added in the form of potassium 
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phosphate 20%.  Table 1.5 indicates ESPGHAN’s guidelines on the provision of these three minerals, although 
owing to the practical pharmacological limitations discussed, additional calcium, phosphorous or magnesium 
may need to be supplemented in other ways in certain clinical scenarios.8,9,29,62 
 
TABLE 1.4 SUMMARY OF DAILY PARENTERAL VITAMIN REQUIREMENTS FOR INFANTS AND CHILDREN, AND CURRENT INTRAVENOUS 
VITAMIN PREPARATIONS AVAILABLE IN SOUTH AFRICA 
Vitamin Infant 
(Dose/kg/d) 
Children 
(Dose per day) 
Soluvit® Novum 
(per 10mL vial) 
Dose 1mL/kg/d 
Vitalipid® Novum Infant 
(per 10mL vial) 
Dose 1mL/kg/d 
Vitamin A (µg) 150 – 300 150 0 690 
Vitamin D (µg) 0.8 (32 IU) 10 (400 IU) 0 10 (400 IU) 
Vitamin E (mg) 2.8 – 3.5 7 0 6.4 
Vitamin K (µg) 10 200 0 200 
Ascorbic acid (mg) 15 – 25 80 100 0 
Thiamine (mg) 0.35 – 0.50 1.2 2.5 0 
Riboflavin (mg) 0.15 – 0.2 1.4 3.6 0 
Pyridoxine (mg) 0.15 – 0.2 1.0 4.0 0 
Niacin (mg) 4.0 – 6.8 17 40 0 
B12 (µg) 0.3 1 5.0 0 
Pantothenic acid (mg) 1.0 – 2.0 5 15 0 
Biotin (µg) 5.0 – 8.0 20 60 0 
Folic acid (µg) 56 140 400 0 
  Source: Adapted from [8; 58; 59] 
 
TABLE 1.5 SUMMARY OF DAILY PARENTERAL CALCIUM, PHOSPHOROUS AND MAGNESIUM REQUIREMENTS 
Age Calcium 
mg (mmol) / kg 
Phosphorous 
mg (mmol) / kg 
Magnesium 
mg (mmol) / kg 
0 – 6 months 32 (0.8) 14 (0.5) 5.0 (0.2) 
7 – 12 months 20 (0.5) 15 (0.5) 4.2 (0.2) 
1 – 13 years 11 (0.2) 6 (0.2) 2.4 (0.1) 
14 – 18 years 7 (0.2) 6 (0.2) 2.4 (0.1) 
  Source: Adapted from [8; 9] 
 
Iron is not currently included in neonatal and paediatric PN, mainly because of concerns of overload and its 
potential to increase the risk of developing gram-negative septicaemia.  Current guidelines do however 
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recommend iron supplementation in long-term PN patients (receiving PN for longer than 3 weeks).8,9,54,57  In 
VLBW infants, the usage remains controversial, as the need exists, but the risks of infection are a concern.29,30  
ESPGHAN reported a grade B recommendation for supplementation of iron in this patient group, but the 
dose is not clearly defined – suggested doses are provided in Table 1.6.8  Many critically ill paediatric patients, 
such as burns and cancer patients, receive multiple blood transfusions which is another reason why 
parenteral iron should not be routinely administered.60,61  Monitoring of iron status in this patient population 
as a whole is recommended to prevent toxicity and ensure that deficiencies can be avoided.9 
The suggested requirements from the ESPGHAN guidelines for chromium, copper, iodine, manganese, 
molybdenum, selenium and zinc are also summarised in Table 1.6, together with the quantities present in 
Peditrace®, the trace element preparation presently available and included in all standard compounded PN 
solutions in South Africa.8,64 
 
TABLE 1.6 SUMMARY OF DAILY PARENTERAL TRACE ELEMENT REQUIREMENTS AND THE CURRENT INTRAVENOUS TRACE ELEMENT 
PREPARATION AVAILABLE IN SOUTH AFRICA 
Trace element ESPGHAN Guideline (2005) Peditrace® 
(µg/1 mL) 
Peditrace® 
(µmol/1 mL) 
Iron Preterm: up to 200 µg/kg/d 
Infant & child: 50 – 100 µg/kg/d 
0 0 
Zinc Preterm: 450 – 500 µg/kg/d 
Infant <3 months: 250 µg/kg/d 
Infant >3months: 100 µg/kg/d 
Child: 50 µg/kg/d (UL 5 mg/kg/d) 
250 3.82 
Copper 20 µg/kg/d 20 0.315 
Manganese 1 µg/kg/d (UL 50 µg/kg/d) 1 0.0182 
Chromium 0.2 µg/kg/d (UL 5 µg/kg/d) 0 0 
Selenium 2 – 3 µg/kg/d 2 0.0253 
Iodine 1 µg/d 1 0.0079 
Fluoride No recommendation 57 3.0 
Molybdenum Preterm: 1 µg/kg/d 
Infant & child: 0.25 µg/kg/d  
(UL 5 µg/kg/d) 
0 0 
  Source: Adapted from [8; 64]  UL, Upper Limit 
 
With many of the trace elements, it is a balancing act between preventing deficiencies and avoiding toxicity.  
Of particular concern in terms of toxicity are copper and manganese, as excess amounts are usually excreted 
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in bile, a process which is obviously inhibited during parenteral nutrition feeding.  It is common practice to 
reduce or exclude copper in cases of cholestasis, and ESPGHAN also recommends monitoring copper intake 
closely in long-term PN.  In terms of manganese, elevated blood values above normal levels, and associated 
deposition in the central nervous system with or without symptoms, have been reported in the literature, 
and it is recommended that especially in long-term PN administration, the quantities of manganese are 
reduced.8,9,54,65–67  It is worth noting, however, that in the South African context this approach is currently not 
possible, as both copper and manganese are included routinely in all available admixtures.64   
In preterm infants and paediatric burns patients, as well as those experiencing high gastrointestinal losses, 
additional copper and zinc may need to be supplemented, but blood levels then need to be closely 
monitored.8,9,30 In oncology patients, some of the chemotherapy medications can result in excess losses of 
magnesium, potassium, phosphate, and calcium – these electrolytes therefore need to be closely monitored, 
and additional supplementation initiated if necessary.60  Although chromium and molybdenum are 
recommended in the ESPGHAN guidelines, they are currently not included in the Peditrace® preparation as 
indicated in Table 1.6.8,64     
 
1.6 Challenges associated with parenteral nutrition in neonatal and paediatric patients 
 
Unfortunately, PN therapy in neonatal and paediatric patients is not without its challenges.  There are 
complications associated with this route of feeding, the risk of infection is a real concern, and actual clinical 
practice often differs greatly from what is stipulated in the guidelines and literature.  Feeding prescriptions 
also are often based on what is available, as opposed to what is considered optimal nutrition for the patient.  
Some of these issues are discussed in this section to highlight the complexity of PN feeding practices in this 
patient population worldwide.8,10,12,13,29,34,68–73 
 
1.6.1 Clinical complications 
 
Of the most prominent challenges, particularly for patients reliant on long-term PN support, are the effects 
on the liver.  Cholestasis can be caused by multiple factors, but there is evidence to suggest that duration of 
PN therapy, the quantity of glucose administered, elevated levels of certain trace elements, as well as the 
type of IVLE, all play a role in its development.9,28,29,40,46,49,74,75  It is important to ensure, where possible, in 
high-risk patients, that these nutrition-related factors are properly managed.  High-risk patients include those 
that receive PN for a prolonged duration (longer than 2 weeks), for example, ELBW infants, and children with 
short-bowel syndrome (SBS).66  The initiation of early enteral feeding, even at minimal trophic levels, is 
beneficial for maintaining gut integrity, as well as reducing cholestasis risk.  Also, where possible, the use of 
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third-generation lipid emulsions (IVLE containing a fish oil component), such as SMOFlipid® should be 
implemented.9,29,43,66,75–78  The main hepato-protective effect seems to be attributed to the fish oil component 
of the SMOFlipid® emulsion.  Tomsits et al. (2010) investigated the safety and efficacy of SMOFlipid® in 
premature infants requiring PN therapy, and noted the potential beneficial role of this IVLE in cholestasis 
management.43  Pichler et al. (2014) compared a soybean / MCT combination lipid, Lipofundin®, with 
SMOFlipid® in patients aged 0–16 years with intestinal failure receiving PN for at least two weeks, and who 
were already showing signs of liver complications.  The Lipofundin® resulted in improved liver parameters 
over time, but the addition of olive and fish oil in the IVLE resulted in the most notable reversal of liver 
abnormalities, as well as less inflammation.47  Goulet et al. (2010) noted improvements in plasma bilirubin 
levels in long-term home PN paediatric patients (aged 5 months to 11 years) receiving PN containing 
SMOFlipid® when compared with Intralipid®.45  Finally, Hoffmann et al. (2014) investigated SMOFlipid® usage 
in paediatric oncology patients undergoing chemotherapy treatment, and although cholestasis incidence did 
not differ between the two groups, possibly owing to the relatively short duration of PN therapy (14 days), 
the SMOFlipid® resulted in lower gamma-glutamyl transpeptidase (GGT) levels.  GGT can be considered an 
early marker of the development of cholestasis and the authors suggested there is therefore early evidence 
for the liver protective effect of SMOFlipid® in this patient group.46     
Hyperglycaemia is also a common problem related to PN therapy, and is directly related to glucose infusion.  
Critically ill and preterm patients are most at risk owing to their relative instability and the presence of sepsis.  
Inhibition of insulin release in these stressed patients exacerbates the elevated blood glucose levels 
further.8,9,29  The early provision of amino acids may promote insulin release, and in many instances the 
amount of glucose in the PN solution may need to be reduced.8  In South Africa, there are lower glucose 
admixtures available for this purpose.  Insulin therapy in neonatal and paediatric patients is not common 
practice, but may be considered if hyperglycaemia persists.8,29,30 
The challenge of feeding optimally is a complex issue, and nutrient deficits place this patient group at risk of 
developing malnutrition.2  Achieving growth and development targets is often hindered by the disease 
process, as well as medical interventions and a lack of adherence to feeding guidelines.  These outcomes 
should be closely monitored, and changes to prevent and treat malnutrition, and promote growth, should be 
implemented if necessary.7,9,28,29   
Another concern in long-term patients is metabolic bone disease associated with PN.  This presents in a 
similar form to rickets, and may be caused by the relative inactivity and the underlying pathology, but also 
by suboptimal calcium and phosphorous provision and utilisation.  These biochemical parameters should be 
closely monitored in patients that are identified as high risk.8,9,29     
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In light of these potential clinical complications, regular monitoring of the patient is imperative.  Table 1.7 
summarises the recommended tests and measurements that should be done in parenterally fed neonatal 
and paediatric patients.8,29 
 
TABLE 1.7 RECOMMENDED MONITORING IN NEONATAL AND PAEDIATRIC PATIENTS ON PARENTERAL NUTRITION 
Test / Measurement Frequency 
Glucose 6 – 8 hourly while increasing glucose infusion rate 
Once or twice daily once on a stable glucose infusion 
Serum electrolytes & urea Twice a week while increasing fluid rate, then weekly 
Serum Ca, Mg, PO4 Weekly 
Liver function tests (LFTs) Weekly 
Serum triglycerides Weekly 
Urinary glucose Daily for first 5 days and then weekly 
Weight, length & head circumference Weekly 
  Source: Adapted from [8;29] 
 
1.6.2 Line access and infection risk 
 
The high nutrient content of PN provides an ideal medium for bacterial and fungal growth, and it is therefore 
imperative that the compounding and administration of PN are completed under strict aseptic conditions.  In 
South Africa, compounding is not done at hospital level at all.  Commercially prepared solutions are 
compounded by Fresenius Kabi at a single site, using barrier isolator technology, producing standardised 
regimens that have been terminally sterilised.  They are then transported under strict cold- chain conditions 
to five distribution dispensaries throughout the country.  The bags are dispensed daily on a patient-specific 
basis, and maintaining the cold chain and rigorous quality measures throughout, are transported to hospital 
dispensaries and finally to the ward to be administered to the patient.8,29,79   
PN requires suitable venous access, and good line care is essential for minimising infection risk.  Where 
possible, particularly if parenteral nutrition therapy is going to exceed 7 days, a peripherally inserted central 
catheter (PICC) or central venous catheter (CVC) should be inserted.  There is evidence to support either the 
use of the jugular or subclavian site, as well as no additional mechanical or infectious risk associated with 
femoral access.  In neonates, it is also considered acceptable practice to utilise the umbilical line initially; 
usage of this access site should however not exceed 5 days or 14 days for arterial and venous catheters 
respectively.  The guidelines are clear that PN solutions containing a lipid emulsion should not hang for longer 
than 24 hours.  Healthcare professionals handling and prescribing the PN should practise good hygiene, and 
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also monitor the access site for signs of infection and compromise, in order to minimise the risk of 
complications.8,9,80   
Donnell et al. (2002) suggested in their findings that the predominant cause of septicaemia in surgical 
neonates and infants was due to bacterial translocation, but this appears to be a controversial result, as their 
methodology in determining translocation was challenged in a subsequent editorial.68  A study by Fivez et al. 
(2016) in critically ill children also investigated PN initiation and the link to infectious complications.  They 
concluded that delaying PN therapy by one week was superior in terms of infection outcomes.35  These results 
should however be interpreted with caution, as the goal of nutrition therapy is to promote growth and 
development, and prevent malnutrition, and it should not be delayed based on a single finding.  The key 
message in the literature remains that the safe, appropriate administration of PN can minimise infection risk 
in neonatal and paediatric patients.81–83 
 
1.6.3 Parenteral nutrition availability 
 
Although a seemingly obvious concept, it is worth noting the role which accessibility to PN may play in feeding 
practices.14,73  In South Africa, the health system is split between a private and state sector.  The state 
hospitals tend to have a more restricted procurement process, and more limited funds, and this has the 
potential to influence the availability of certain drugs, including PN.  Also, as mentioned previously, Fresenius 
Kabi is currently the sole supplier of neonatal and paediatric PN in the country, and distributes the 
compounded bags from a single central compounding facility to five dispensaries located in the major city 
centres.  It seems logical that areas considered further away from these dispensaries, may potentially 
experience delays and therefore the ability to commence PN therapy, in comparison with hospitals in the 
direct vicinity.84,85  
In any country, the product registration of a drug will also determine its availability – the current standard 
PN formulations that are available in South Africa consist of preparations that are approved and registered 
with the Medicines Control Council (MCC) and the Department of Health (DoH).84,86 
Finally, the pharmacology involved in producing a stable product may be a limiting factor in terms of what 
feasibly can be provided in a PN solution.  Amino acids, electrolytes, and minerals such as calcium and 
phosphorous, present particular challenges in terms of compounding a nutritionally optimal admixture that 
is also stable.8,37,57,62,63,67 
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1.6.4 Adherence to guidelines in clinical practice 
 
The current available guidelines have been discussed in detail in Section 1.5, but it is evident from surveys 
and audits conducted in neonatal and paediatric intensive care units (ICUs) worldwide, that knowledge of 
guidelines does not necessarily translate into actual clinical practice.10–13,87  Moreno et al. (2016) reported 
notable differences between predicted requirements for the nutrition therapy administration, intended 
prescription, and actual protein and energy delivery in a single paediatric ICU in Brazil.  In this single-centre, 
prospective cohort study, they noted that actual energy and protein provision comprised half of the 
estimated requirements and that 68% of the patients were underfed.  The main reasons for this finding 
appeared to be suboptimal prescription as well as recurrent interruptions to the administration of feeds.13  
Turpin et al. (2013) described similar findings in their medical chart review in German neonatal ICUs.  The 
results from survey studies suggest that although the PN guidelines are often known by the healthcare 
professionals, the intention to treat differs greatly from what is achieved.  They noted that only 30% of their 
preterm patients received amino acids within the first day of life, and 34% received IVLE by day 3, despite 
apparent knowledge of the guidelines.87  Lapillonne et al. (2013) conducted a large survey including 74% of 
the neonatal units in Germany, France, Italy, and the United Kingdom, to investigate adherence of the unit 
protocols to international guidelines, and also the factors that influence compliance.  They found large 
variations in parenteral feeding protocols and feeding practices, and that the size of the hospital, number of 
neonatal beds, and location did not have a significant influence on prescribing patterns.  Amino acids were 
often not administered within the first day of life, and both amino acids and IVLE were commenced at lower 
doses than recommended by the ESPGHAN international guidelines.  The authors noted that the variation in 
lipid administration may be due to a lack of clear scientific evidence and guidance for clinicians in this regard.  
Interestingly, the academic institutions in this study were more likely to introduce lipid earlier in their 
preterm infants, as well as administering higher glucose infusions at PN initiation.  This study also highlighted 
that the international guidelines may be too theoretical, and therefore difficult to implement in clinical 
practice, and that some units relied more heavily on clinical practice protocols than the ESPGHAN 
publication.12 
There is a relative paucity of literature examining the knowledge of doctors and dietitians in relation to PN in 
neonatal and paediatric patients.  Most of the studies that have considered healthcare professionals’ 
knowledge of the international guidelines have only focused on knowledge of the protein targets in this 
patient group, as the primary objectives of the studies have been to assess prescribing practices.  Ahmed et 
al. (2004) conducted telephonic interviews with physicians, and noted that 65% of respondents did not know 
the target dose for parenteral amino acid provision in VLBW infants.  It should however be noted that this 
study was prior to the publication of the ESPGHAN guidelines in 2005.88  Grover et al. (2008) found that only 
27% of the pharmacists surveyed knew the target dose for amino acids.17  Lapillonne et al. (2009) showed 
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improved knowledge of protein targets, with 92% of physician respondents knowing the target should be ≥ 
3 g/kg/day on commencement of parenteral feeding, and 44% aiming for the 3.5 – 4 g/kg/day 
recommendation in their VLBW patients.11   
There appears to be high variability in terms of the healthcare professionals involved in making PN feeding 
decisions, as well as their application of the knowledge and guidelines in clinical practice.  The literature does 
highlight the importance of and need for ongoing training and education in this regard, and there is evidence 
that improved awareness, as well as implementing standardised clinical protocols, can have beneficial results 
for improved practice.10–12,72,88–91  Jadcherla et al. (2016) examined the impact of implementing a feeding 
quality improvement programme involving a standardised feeding strategy for premature infants.  Although 
the focus was more on EN feeding, their findings highlight that with clear feeding guidelines, the progression 
of feeds and thereby achievement of growth goals can be significantly improved.91 
Currently, in the South African context, only two studies have been conducted to survey the feeding practices 
in preterm infants.  The focus of both was on EN, and only premature and low birth weight (LBW) infants, so 
although different, their findings are useful in providing insight into response rates, overall approaches to 
feeding in this patient group, and feeding practice within the South African healthcare environment.  Raban 
et al. (2013) targeted paediatricians and described the commencement of enteral feeds within the first 24 
hours of life.  Only a quarter of the neonatal patients (< 25 weeks gestational age) received EN feeds on day 
1.  The research also provided insight into access to fortification and donor milk, as well as feeding goals in 
this patient group.  Bradfield et al. (2016) investigated EN practices of doctors and dietitians in both the 
private and state sectors.  They noted significant differences in the initiation of feeding between the state 
and private hospital setting – the prescribers working in state hospitals were more likely to commence EN 
nutrition therapy earlier than those in private hospitals.  Dietitians were also significantly more likely to 
calculate protein requirements for their patients, than the doctors.85,92 
 
1.7 Standardised versus individualised parenteral nutrition 
 
The way in which PN for neonatal and paediatric patients is compounded and prescribed differs greatly 
around the world.  Some units rely on individualised preparations done by their hospital pharmacy on site; 
others have a combination of standardised formulations and individualised compounding; and others, as in 
South Africa, rely on commercially prepared standardised bags.  The debate in favour of either is ongoing, 
but overall the literature seems to suggest that the use of standardised all-in-one PN solutions is feasible and 
safe; minimises the risk of errors and misuse (for prescribing and compounding); and can assist in optimising 
nutrient delivery.  It also appears to be a cost-effective approach, and increases the availability of parenteral 
nutrition without the need for onsite compounding facilities and trained staff.  Contamination, and therefore 
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the associated infection risk, also seem to be minimised through the use of premixed PN solutions.14,15,73,79  
The stability of standardised formulations can also be more readily achieved and maintained.37,93 
The challenge with standardised solutions seems to lie mainly in their lack of flexibility.  Certain patient 
groups, such as the VLBW and ELBW neonates, and critically ill children, may require a solution that is tailor-
made for their biochemical and nutritional needs.  The main concern appears to be the need to manipulate 
the electrolytes and overall fluid in certain clinical situations.  Perhaps the best solution is having access to a 
combination of standardised and individualised admixtures.14–16,79,94 
The context in which PN feeding is done will likely dictate whether standardised or individualised PN is the 
best option – in South Africa, the commercially prepared formulations suit the economic, and environmental 
climate in which healthcare is currently provided.79,84 
 
1.8    Motivation for research study 
 
PN has a fundamental role to play in the nutritional management of many neonatal and paediatric patients, 
and it is evident from the literature that its use may be influenced by several factors.  The paucity of data 
describing PN use in this patient group within the South African health context, motivated the research study. 
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Chapter 2:  Research Design and Methodology  
 
In this chapter, the research methodology is described in detail.  The research question, study aim and 
objectives, as well as the complete study plan that was followed, are provided.   
 
2.1 Research question 
 
What are the current paediatric and neonatal PN prescribing practices in South Africa, and what factors 
influence and guide these practices, with special emphasis on knowledge? 
 
2.2 Aim of the investigation 
 
The aim of the investigation was to identify the current paediatric and neonatal PN prescribing practices in 
South Africa. 
 
2.3 Objectives of the investigation 
 
The study objectives were designed to be achieved through the use of a questionnaire and included the 
following (see Figure 2.1 for conceptual framework): 
i. To determine the prescribing practices of PN by paediatric medical specialists and dietitians in South 
Africa. 
ii. To determine the factors that influence PN usage by paediatric medical specialists for their patients 
in South Africa. 
iii. To determine where PN prescribers access PN information and guidelines. 
iv. To determine PN prescribers’ knowledge of the ESPGHAN international guidelines (referred to as the 
ESPGHAN guidelines going forward) and recommendations on feeding practices relating to PN in 
paediatric and neonatal patients. 
v. To compare the subgroups (work sector – state/private) in terms of PN prescribers’ feeding practices 
and factors related to their PN use. 
vi. To compare the subgroups (profession – dietitian/paediatric doctor) in terms of PN feeding practices 
and knowledge of international guidelines. 
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          FIGURE 2.1 CONCEPTUAL FRAMEWORK FOR ACHIEVING STUDY AIMS AND OBJECTIVES 
          PN: Parenteral Nutrition; ESPGHAN: European Society for Paediatric Gastroenterology, Hepatology and Nutrition
Identify paediatric and neonatal parenteral nutrition 
prescribers (medical specialists and dietitians) in the 
private and state hospitals in South Africa
Data Collection Tool -
Self-administered Questionnaire
Data Collection
Comparison between subgroups -
work sector (state vs. private) and 
profession (dietitian vs. paediatric 
doctor)
To determine the prescribing 
practices of PN by paediatric 
medical specialists and dietitians in 
South Africa
To determine the factors that 
influence PN usage by paediatric 
medical specialists for their patients 
in South Africa
To determine PN prescribers’ knowledge 
of the ESPGHAN guidelines and 
recommendations on feeding practices 
relating to PN in paediatric and neonatal 
patients
To determine where they access 
information and guidelines on PN from
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2.4 Null hypothesis 
 
H0:  There is no difference in the PN prescribing practices and knowledge of the ESPGHAN guidelines between 
the work sector subgroups (state and private hospital sectors). 
H0L:  There is no difference in the PN prescribing practices and knowledge of the ESPGHAN guidelines 
between the profession subgroups (dietitians and paediatric doctors). 
 
2.5 Study design 
 
This was an observational, descriptive, cross-sectional study (questionnaire survey) with an analytical 
component. 
 
2.6 Study population 
 
The study population consisted of all paediatric medical specialists and dietitians working with neonatal 
and/or paediatric PN in South Africa.  The targeted study population was a relatively small group of specialist 
dietitians and medical specialists (estimated based on the number of neonatal and paediatric units in both 
private and state hospitals in South Africa).  As Fresenius Kabi is the sole supplier of PN to this patient group 
in the country, the company was able to provide insight into usage in the hospitals.  There are 197 hospitals 
ordering neonatal and paediatric PN bags regularly, 69 (35%) state, and 128 (65%) private sector 
institutions.95 
 
Inclusion criteria: 
Identified neonatal and/or paediatric PN prescriber.  For the purposes of this study, the ‘prescriber’ was 
defined as a registered dietitian or medical specialist (medical officer training in paediatrics/paediatrician/ 
paediatric specialist/neonatologist) assisting with the prescription of, or prescribing PN in neonatal or 
paediatric patients on a weekly basis.  
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 40 
 
Exclusion criteria: 
Paediatric medical specialist or registered dietitian not currently working in a neonatal and/or paediatric 
intensive care unit in South Africa, or prescribing PN in this patient group less frequently than on a weekly 
basis. 
Sampling: 
The sample size calculation was based on the primary objective. To describe paediatric PN prescription 
practices in South Africa with a precision of 17%, 83% power and a 95% confidence interval, 70 participants 
needed to be included. 
For sub-group analyses, Objective (v) and (vi), a minimum of 30 participants per group was required for 
hypothesis testing. This was calculated with a power of 85% and a small–medium effect size of RMSSE=0.55.  
Purposive sampling was used, as all identified prescribers, as defined by the inclusion criteria, were included 
in the study.  The final study sample consisted of all the respondents to the questionnaire from this target 
group. 
The study population was stratified according to work sector (state / private) or professional group (dietitian 
/ paediatric doctor) for the purposes of the analytical component of the study.    
 
2.7 Data collection 
  
2.7.1 Recruiting of study participants 
 
The potential study participants were accessed via the organisations and societies that communicate 
regularly with them.  For the dietitians, the Association for Dietetics in South Africa (ADSA) was used as a 
means of inviting the prescribers to participate in the survey.  ADSA sent out an advertorial as part of their 
regular communication with their members, providing details of the research and inviting dietitians involved 
in neonatal and paediatric parenteral nutrition prescription to follow the online survey link and complete the 
questionnaire.  The paediatric medical specialists were reached via the South African Paediatric Association 
(SAPA).  SAPA sent an email with the research information and a link to the survey to its members, but the 
initial contact process yielded no response from this target group.   
A second round of contacts was initiated with the potential study participants in order to improve 
questionnaire response rates.  This involved another advertorial via ADSA.  The medical specialists were then 
recruited by the researcher contacting them directly.  For state hospitals, the heads of paediatric 
departments were emailed with information on the study and a link to the questionnaire to distribute to 
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their individual teams of doctors.  For the private sector hospitals, the main hospital groups were identified 
– Life Healthcare, Mediclinic, Netcare and Independent.  The Life Healthcare and Independent hospitals had 
little information available on their websites so had to be excluded from this recruiting process.  The 
Mediclinic and Netcare websites had detailed lists of all their paediatric healthcare professionals, and in most 
cases included a contact email address.  These email addresses were used to send the study information and 
a survey link directly to the medical specialists.  
 
2.7.2 Questionnaire development and composition 
 
No validated questionnaire tool for this study was available, so related questionnaires were used as a guide 
to develop a new questionnaire based on the study objectives.  The questionnaire consisted of 35 questions, 
including questions linked to relevant demographic information; PN prescription practices; the potential 
factors related to PN usage; information access; and overall knowledge of the PN guidelines.   
PN prescription factors were assessed in terms of timing, patient type and diagnosis, use of macronutrients 
(protein, glucose and lipid), and fluid allocations.  Previous studies have focused predominantly on the dosage 
and timing of macronutrients in PN prescription, so this was included as a key component of the prescription 
factor assessment.10,12,72  The ESPGHAN Guidelines have a dedicated chapter for fluid in terms of PN 
management, so the decision was made to include fluid practices in the questionnaire.8  Prescriber 
knowledge of the ESPGHAN guidelines was assessed, as well as access to information.8  The decision to use 
the ESPGHAN guidelines as a gauge of knowledge was based on the availability of the information and the 
fact that they were currently the only concise, clear, defined guidelines for parenteral nutrition in this patient 
group that could be found after extensive searches.  They represent a collective opinion for nutrition in this 
patient population based on the clinical evidence available, and were viewed as ‘best practice’ at the time of 
questionnaire development and distribution. No previous questionnaire assessing knowledge in this way was 
available, so the knowledge questions were developed with the guidance and assistance of expert opinion, 
and refined during the validation process.  Factors that may influence PN prescribing practices such as 
resource availability, years of practice, frequency of scripting, provincial location, work sector (state/private), 
and experience with PN were also included.  If the participant was involved in both state and private sector 
hospitals, he/she was asked to complete the questionnaire based on the work sector in which the majority 
of prescriptions was completed.  Please refer to Addendum A for the questionnaire. 
The content validity of the developed questionnaire was reviewed by a selected panel of five clinical dietitians 
and neonatologists before implementation.  The panel adjusted the wording of some of the questions, 
ensured that both the neonatal and paediatric patient feeding practices were addressed, and that the 
knowledge questions were clear and easy to understand, and covered the main aspects of PN feeding.  The 
Stellenbosch University  https://scholar.sun.ac.za
 42 
 
face validity was assessed by conducting the questionnaire with 3 identified dietitians and medical specialists 
with previous experience in neonatal and paediatric PN, but who did not meet the inclusion criteria for the 
study as they were not actively prescribing PN at the time.  A few minor amendments to the questionnaire 
were necessary to improve question understanding as well as content. An additional 2 identified prescribers 
who also met the criteria of the pilot group were then asked to test the finalised, online survey system for 
face validity, ease of use, and time to complete the questionnaire (10 minutes).  This pilot and test were 
completed before the questionnaire was made available for completion by the identified study participants. 
 
2.7.3 Questionnaire administration 
 
The data was collected by means of a self-administered online questionnaire via SurveyMonkey®.  Each 
participant was allocated a code to ensure anonymity during the data-collection and analysis processes.  A 
cover letter and informed consent document were included in the electronic system. Completion of the 
survey online was viewed as providing consent. An incentive, in the form of entrance into a ‘lucky draw’ for 
a relevant academic conference sponsorship (to the value of R3500.00) was offered for completion and 
submission of the questionnaire.  Participants were allowed to choose to participate in this draw by 
submitting their contact email after completing the questionnaire. 
As this was a self-administered questionnaire, the need for training and standardisation was eliminated, and 
inter-observer variation was not a concern.  The pilot process helped to ensure that the questions were well 
formatted and phrased, thereby improving the quality of the data captured. Incomplete questionnaires were 
used for the relevant completed sections. The participants that failed to conform to the inclusion criteria 
were excluded and did not form part of the study.  These were identified as survey respondents who do not 
actively prescribe or recommend PN feeding in neonatal or paediatric patients (they answered ‘no’ to both 
Questions 6 and 8; see Addendum A).   
 
2.8 Analysis of data 
 
2.8.1 Data capture 
 
The data was captured using Microsoft Excel 2013, and based on the pre-established coding system.  
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2.8.2 Statistical analysis 
 
Statistical analysis was done using STATISTICA™ version 13.2 (StatSoft Inc. 2016 STATISTICA data 
analysis software system, www.statsoft.com). Basic analyses for the descriptive data included the 
summary of the data into categories, and pivot table representations of this information.  General frequency 
responses from the questionnaire data were calculated and used to assess potential associations between 
the categorical variables (e.g. primary reasons for use of PN; duration of practice; frequency of PN use).  The 
chi-squared (χ2) test was used for analyses between nominal variables (e.g. calculation of the various nutrient 
requirements; profession; work sector); the Mann–Whitney U Test for comparisons between not normally 
distributed nominal and continuous variables (e.g. commencement of PN; practice score; knowledge score); 
and Spearman’s rank correlation coefficient for continuous variable analysis.  The significance level was set 
at 95% (p < 0.05).  This process was completed with the assistance of the statistician from the Centre for 
Statistical Consultation at Stellenbosch University. 
  
The practice scores were determined by combining several of the questions related to clinical practice.  The 
commencement of PN, introduction of lipid, and calculation of patient-specific requirements were 
considered.  Best practice was allocated the highest score – commencing PN within 24 hours (3 points); 
introducing lipid from day 1 (3 points); and always calculating requirements for protein, energy, glucose 
oxidation rate and fluid (2 points each).  A maximum score of 14 was achievable, and the combined scores 
were reflected as a percentage of this total.  The PN practices assessment was analysed based on a 
competency of 60%.  Owing to no references for practice scores being available, it was decided a priori to 
use 60%. 
The analysis of the knowledge assessment was based on a comparison with the 2005 ESPGHAN Guidelines 
on Parenteral Nutrition in Paediatrics.8  The relevant questions (Numbers 21 to 35, see Addendum A: 
Questionnaire) were marked for correctness and one point allocated for each correct answer.  These points 
were collated to form the knowledge score, and a maximum of 15 points was achievable.  The knowledge 
scores are reflected as a percentage.  Once again, owing to the lack of available references for knowledge 
assessment scoring, it was decided a priori to use an 80% competency.     
 
2.9 Financial disclosure 
 
The research was self-funded. 
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2.10 Ethics approval 
 
In accordance with the National Health Act, No. 61 of 2003, ethics approval was obtained from the 
Stellenbosch University Health Research Ethics Committee (HREC) – S14/10/252.  The use of communication 
channels via the established dietetic and paediatric organisations, and readily available information online, 
also ensured the voluntary nature of study participation and protection of the participants’ personal contact 
information.  
Coding was used throughout the data-collection and analysis process to ensure that answers could not be 
linked to a specific name on the sample population list.  The use of an online survey system also allowed the 
anonymity of the participants to be maintained during the data-collection process.   
The online survey included a cover letter informing the participants about the proposed research and their 
involvement, and an informed consent document.  Their agreement to participate in the survey was included 
in this consent process. 
Data management was overseen by the primary researcher, and data was stored on an external hard drive 
as well uploaded to an online ‘cloud’.  All access to this data was password protected to ensure limited 
access to the information. 
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Chapter 3: Results 
 
In this chapter the study findings are presented and summarised. 
 
3.1 Demographic characteristics 
 
A total of 83 respondents commenced with the questionnaire.  Based on the estimated targeted sample 
population, this is a response rate of 42%.  Figure 3.1 depicts the flow of participation in the survey.  Four 
respondents (5%) were excluded from the data analysis due to their only completing the first question in the 
survey; and one (1%) did not conform to the inclusion criteria as he/she did not prescribe PN in this patient 
group at all.  A further six (7%) were excluded as they exited the survey after answering only the first five 
questions (providing basic demographic data).  The final sample consisted of 72 respondents. A further eight 
(10%) respondents did not complete the knowledge section of the questionnaire (Questions 25 – 35), and a 
sample of 64 was therefore utilised for data analysis in this component. 
The first section of the questionnaire explored the demographic characteristics of the study respondents.  
Table 3.1 provides an overview of these findings.  There was a relatively even split between those working in 
the private and state health sectors.  If the respondents worked in both sectors, they were asked to specify 
where they were predominantly based, and answer the survey based on these experiences and setting.  
Interestingly, the split within the state sector between the smaller regional and secondary hospitals, and the 
larger academic institutions, was equal.  The majority of the respondents worked in units with more than 6 
beds for neonatal or paediatric patients. 
There were more dietitians than paediatric doctors that completed the survey, but a relatively good 
distribution of specialists within the latter group.  Unfortunately, no paediatric surgeons or paediatric 
cardiologists responded to the survey.  The respondents had variable years of experience, but overall there 
was good representation across the group. 
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All ADSA and SAPA members invited to participate in the study 
Targeted emailing of paediatric medical specialists - state HOD, private hospital group contact lists 
 
 
 
 
FIGURE 3.1 FLOW CHART INDICATING PARTICIPATION IN THE STUDY 
ADSA: Association for Dietetics in South Africa; SAPA: South African Paediatric Association; HODs: Heads of Department; ESPGHAN: 
European Society for Paediatric Gastroenterology, Hepatology and Nutrition 
 
The survey also noted the provincial location of the study participants.  The provincial distribution is shown 
in Figure 3.2.  The survey responses were based predominantly in the Gauteng province (51%), followed by 
KwaZulu-Natal (18%) and the Western Cape (14%).  There was no representation from Limpopo and the 
Northern Cape.    
 
Main inclusion criterion:  Dietitians and paediatric doctors actively working with parenteral nutrition 
prescriptions in neonatal and paediatric patients
n = 4  Excluded as only completed the first question of the survey
n = 1 Excluded from study due to not meeting study inclusion criteria
n = 6  Exited from study voluntarily (reasons unknown)
n = 8 Exited from the study voluntarily (reasons unknown)
n = 83 Responded to survey request 
 
 n = 36 (46%) – Private sector 
 n = 43 (54%) –  State sector 
n = 79 Continued with study 
 
n = 78 Continued with study 
 
n = 72 Continued with questions on hospital 
setting and clinical practice 
 
n = 64 Continued with questions on knowledge 
of ESPGHAN guidelines 
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TABLE 3.1  SUMMARY OF THE DEMOGRAPHIC CHARACTERISTICS OF THE SURVEY RESPONDENTS 
Hospital sector (n = 72) n % 
Private 
Exclusively private hospital 
Both – predominantly private hospital 
State 
Regional / secondary hospital 
Academic / tertiary hospital 
Both – predominantly state hospital 
 
34 
32 
2 
38 
16 
16 
6 
47 
94 
6 
53 
42 
42 
16 
Number of beds in neonatal / paediatric unit (n = 72) n % 
1 – 5 beds 
6 – 10 beds 
> 10 beds 
 
10 
32 
30 
14 
44 
42 
Profession (n = 72) n % 
Dietitian 
Doctor 
- Medical Officer (MO) 
- Neonatologist 
- Paediatrician 
- Paediatric Intensivist 
- Paediatric Pulmonologist 
 
42 
30 
1 
2 
19 
7 
1 
58 
42 
3 
7 
63 
23 
3 
Duration of practising and working with PN prescriptions (n = 72) n % 
0 – 2 years 
3 – 5 years 
6 – 10 years 
11 – 20 years 
> 20 years 
 
12 
21 
16 
19 
4 
17 
29 
22 
26 
6 
 
 
FIGURE 3.2 PROVINCIAL DISTRIBUTION OF THE SURVEY RESPONDENTS 
EC: Eastern Cape; FS: Free State; GT: Gauteng; KZN: KwaZulu-Natal; MP: Mpumalanga; NW: North-West;  
WC: Western Cape 
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3.2 Parenteral nutrition feeding practices 
 
3.2.1 Parenteral nutrition usage and nutrient calculations 
 
The survey respondents were asked to rank their reasons for PN usage in their neonatal and paediatric 
patients.  The primary reasons for prescribing or recommending PN feeding were determined by combining 
the frequencies of a 1–3 ranking for each category.  Figure 3.3 provides a graphical summary of these findings.  
Gut anomalies and intolerances, prematurity, critical illness, and post-operative need were the main clinical 
indications for PN usage.  Unfortunately, the respondents who chose other reasons as their main reason, did 
not specify which conditions these might be.  The more specialised categories, oncology and burns, were far 
less common as a predominant reason to utilise PN.   
  
 
FIGURE 3.3 PRIMARY REASONS FOR USE OF PARENTERAL NUTRITION IN NEONATAL AND PAEDIATRIC PATIENTS 
 
In addition to the clinical indications linked to PN usage, the questionnaire investigated the type of patient 
(neonates and/or paediatric patients) and frequency of PN prescription.  These findings are summarised in 
Table 3.2.  Usage of PN was slightly more prevalent in neonatal patients.  When asked how often they 
prescribed or recommended PN in their patients, the majority of the respondents only used PN once a week.  
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TABLE 3.2 SUMMARY OF THE PATIENT TYPE AND FREQUENCY OF PARENTERAL NUTRITION USAGE 
Neonatal and paediatric PN use (n = 72) n % 
Dietitians 
- Neonatal PN use 
- Paediatric PN use 
Doctors 
- Neonatal PN use 
- Paediatric PN use 
 
42 
38 
31 
30 
19 
17 
58 
90 
74 
42 
63 
57 
Frequency of PN use (n = 72) n % 
Neonatal PN use 
- Daily 
- 2 – 3 times per week 
- Once a week 
Paediatric PN use 
- Daily 
- 2 – 3 times per week 
- Once a week 
 
57 
13 
12 
32 
48 
5 
11 
32 
79 
23 
21 
56 
67 
10 
23 
67 
 
The questionnaire also asked respondents to indicate how often, if at all, they calculated the various 
macronutrient requirements for their patients.  Responses were categorised as ‘always’, ‘sometimes’ or 
‘never’.   Table 3.3 shows the frequency of patient-specific calculation for the group as a whole, but also 
stratified by profession.  In general, the dietitians were more likely to calculate requirements for energy and 
protein, as well as the glucose oxidation rate.  It was found that the doctors prioritised fluid calculation in 
determining their PN prescription.   
TABLE 3.3 SUMMARY OF CALCULATION OF PATIENT-SPECIFIC MACRONUTRIENT REQUIREMENTS 
Calculation of requirements (n = 72) Total 
group 
Dietitians Paediatric 
doctors 
n % n % n % 
 
Energy 
- Always calculate patient energy requirements 
- Sometimes calculate patient energy requirements 
- Never calculate patient energy requirements 
Glucose oxidation rate 
- Always calculate the glucose oxidation rate 
- Sometimes calculate the glucose oxidation rate 
- Never calculate the glucose oxidation rate 
 
Protein 
- Always calculate patient protein requirements 
- Sometimes calculate patient protein requirements 
- Never calculate patient protein requirements 
Fluid 
- Always calculate patient fluid requirements 
- Sometimes calculate patient fluid requirements 
- Never calculate patient fluid requirements 
 
72 
 
42 
23 
7 
 
24 
23 
25 
 
44 
21 
7 
 
60 
9 
3 
100 
 
58 
32 
10 
 
33 
32 
35 
 
61 
29 
10 
 
83 
13 
4 
42 
 
33 
8 
1 
 
18 
19 
5 
 
35 
7 
0 
 
32 
7 
3 
58 
 
79 
19 
2 
 
43 
45 
12 
 
83 
17 
0 
 
76 
17 
7 
 
30 
 
9 
15 
6 
 
6 
4 
20 
 
9 
14 
7 
 
28 
2 
0 
42 
 
30 
50 
20 
 
20 
13 
67 
 
30 
47 
23 
 
93 
7 
0 
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Of particular interest, were the differences between the two professions in terms of protein and fluid 
calculation.  The dietitians were significantly more likely to calculate the protein requirements for their 
patient (n = 35, 83%) compared with the doctors (n = 9, 30%); (p < 0.001, chi-squared 26.49).  Only one-third 
of the doctors (n = 9, 30%) always calculated protein requirements.  Although not significant, the doctors 
were definitely more likely to calculate fluid (n = 28, 93%) in comparison with the dietitians (n = 32, 76%); (p 
= 0.069, chi-squared 5.36).  These findings are graphically represented in Figures 3.4 and 3.5 respectively. 
 
 
FIGURE 3.4 CALCULATION OF PROTEIN REQUIREMENTS BASED ON PROFESSION 
 
 
FIGURE 3.5 CALCULATION OF FLUID REQUIREMENTS BASED ON PROFESSION 
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3.2.2 Timing of parenteral nutrition commencement and lipid introduction 
 
Prescription practices include not only the calculation of requirements, but also the practical implementation 
of PN feeding.  The questionnaire investigated the timing of both PN commencement, as well as lipid 
introduction to the PN prescription.   
Figure 3.6 shows the timing of PN feeding commencement for the total respondent group, as well as per 
hospital sector.  Just over a third of the survey respondents commenced PN feeding of their neonatal or 
paediatric patients within the first 24 hours; the majority, about half, started on day 2 (24 – 48 hours), and 
some started on day 3 (49 – 72 hours).  One of the respondents started with PN feeding later, only 
commencing with PN in their patients by day 7.  Private hospital respondents were more likely to start earlier 
with PN than state hospital respondents – the majority of private sector respondents started within the first 
two days.  State hospital respondents started predominantly on day 2.  There was, however, no significant 
difference between the private and state sector subgroups (p = 0.644).    
 
 
FIGURE 3.6 TIMING OF PARENTERAL NUTRITION COMMENCEMENT IN NEONATAL AND PAEDIATRIC PATIENTS BASED ON HOSPITAL 
SECTOR 
Day 1: Within 24 h; Day 2: Within 24 – 48 h; Day 3: Within 49 – 72 h; Later: Specified Day 7; PN: Parenteral Nutrition. 
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The questionnaire asked the respondents to specify how soon they included lipid as part of their PN 
prescription.  The majority of the survey respondents actually did introduce lipid from day 1 of PN feeding (n 
= 48, 67%), some commenced with lipid as part of the PN from day 2 (n = 21.29%), and the remainder 
introduced lipid after day 3 (n = 3.4%).  There was no significant difference between the practices in the state 
and private sectors for the timing of lipid introduction (1.39 ± 0.75 days state versus 1.44 ± 0.66 days private;  
p = 0.783).   
The respondents that delayed lipid (n = 24.33%), defined as starting after day 1 of PN feeding, were asked to 
indicate the main reason for this practice.  Figure 3.7 provides a graphical summary of the results.  The 
predominant reason for this practice was habit, followed by concerns about liver function, and also PN 
availability.  Respiratory function, line tissuing, and metabolic acidosis appeared to be less of a concern to 
the respondents in relation to lipid introduction.  Only one of the two respondents that stated other reasons 
for lipid delay gave additional information, stating that it is was the paediatrician’s preference to do so. 
 
 
FIGURE 3.7 SUMMARY OF THE REASONS LIPID INTRODUCTION IS DELAYED 
PN: Parenteral nutrition 
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3.2.3 Practice scores 
 
In order to quantify the practices of the respondents in relation to their PN feeding prescriptions, a practice 
score was generated.  The practice score was determined by combining several of the questions related to 
clinical practice. The commencement of PN, introduction of lipid, and calculation of patient-specific 
requirements were considered.  A maximum score of 14 was achievable, and the combined scores were 
reflected as a percentage of this total.  Figure 3.8 illustrates the percentage of respondents achieving best 
practice by question, as well as indicating the baseline competency of 60%. 
 
 
FIGURE 3.8 SCORES FOR BEST PRACTICE FOR PARENTERAL NUTRITION USAGE IN NEONATAL AND PAEDIATRIC PATIENTS 
PN: Parenteral Nutrition; h: hours 
60% considered baseline competency for clinical practice score 
 
The mean practice score was 75% (SD ± 17).  The survey respondents achieved competencies for three of the 
aspects assessed.  Calculation of fluid requirements was the most optimal practice, followed by the timing of 
lipid introduction and calculation of patient-specific protein requirements.  Calculation of energy 
requirements was just below competency, at 58%.  The final two factors were almost half of the baseline 
competency level – commencement of PN within 24 hours of admission, and calculation of the glucose 
oxidation rate were rarely achieved to best practice standards.  Interestingly, there was a significant negative 
correlation between the timing of PN feeding commencement and the overall practice score achieved – the 
group of survey respondents that did commence PN feeding within the first day were significantly more likely 
to achieve a high overall practice score, as shown in Figure 3.9 (r = - 0.48; p < 0.001). 
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FIGURE 3.9 CORRELATION BETWEEN THE TIMING OF PARENTERAL NUTRITION COMMENCEMENT AND PRACTICE SCORE ACHIEVED 
 
Comparison of the mean scores for the state and private sector showed no significant difference between 
the two subgroups (75 ± 20% state versus 76 ± 15% private; p = 0.82).  As shown in Figure 3.10, the mean 
practice score for the dietitians was however significantly higher than for the doctors (82 ± 12% versus 65 ± 
19 %; p < 0.001).  Surprisingly, a weak negative association was found between the number of years of 
clinical experience and the practice score (r = - 0.17; p = 0.16). 
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FIGURE 3.10 COMPARISON OF THE MEAN PRACTICE SCORES BY PROFESSIONAL SUBGROUP 
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3.3 Factors affecting parenteral nutrition usage 
 
The questionnaire aimed to investigate potential factors that might influence clinical practice in terms of PN 
feeding.  The survey respondents were asked to rank the reasons they might not use PN or delay the use of 
PN when it was indicated (rank from 1 – 8, blank if not applicable).  Table 3.4 summarises the frequency of a 
number 1–3 ranking for each factor, indicating the primary reason for non-use or delay of PN feeding.  
Concern relating to infectious complication risk was the most predominant factor influencing PN usage.  The 
high cost of PN also played a major role in avoidance of PN feeding.  The lack of access to neonatal and 
paediatric PN, as well as a lack of trained staff to administer the PN to patients, also featured quite highly as 
factors influencing PN prescription practices.  Unfortunately, those that selected ‘other’ as their main reason 
for non-use or delay, did not provide further explanation.  This was also quite a predominant factor, so 
elaboration by respondents on these additional reasons would have been interesting.  Budget limitations of 
the institution, medical aid limitations, and a lack of PN knowledge appeared less important in influencing 
the utilisation of PN.   
 
TABLE 3.4 FACTORS AFFECTING THE NON-USE OR DELAYED USE OF PARENTERAL NUTRITION IN NEONATAL AND PAEDIATRIC 
PATIENTS 
Main reason for not using or delaying PN (n = 72) n % 
High cost of PN 
Budget limitations in the institution 
Concerns regarding infectious complications 
Lack of trained staff 
Lack of access to PN 
Lack of knowledge 
Medical aid limitations* 
Other (unspecified) 
 
24 
8 
42 
16 
18 
9 
11 
18 
33 
11 
58 
22 
25 
13 
15 
25 
*Medical aid limitations only applicable to the private hospital sector in South Africa 
PN: Parenteral Nutrition 
 
3.4 Respondent knowledge assessment 
 
3.4.1 Access to information 
 
The survey respondents were asked to indicate which potential sources of information they utilised, by 
ranking them from 1 – 7, or leaving the question blank if not applicable.  Table 3.5 provides a summary of the 
frequency of use as a primary information source (ranked number 1–3).  Published guidelines (65%) and 
journal articles (63%) were the most frequently accessed information sources.  Interestingly, published 
guidelines were listed by almost half of the respondents as their number 1 resource.  Congress and 
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conference lectures, study notes and discussions with company representatives were also utilised quite 
readily as sources of information on PN feeding.  Only 18 (25%) of the respondents listed journal clubs, ward 
rounds and internal meetings as their main sources of information.  Unfortunately, those that selected ‘other’ 
as their main information source, did not elaborate on the additional resources they accessed. 
 
TABLE 3.5 SUMMARY OF INFORMATION SOURCES UTILISED BY SURVEY RESPONDENTS 
Information source (n = 72) Primary source of information 
 
n % 
Journal articles 
Congress and conference lectures 
Journal clubs, ward rounds and internal meetings 
Company representatives 
Lecture notes from their studies 
Published guidelines 
Other (unspecified) 
 
45 
33 
18 
24 
23 
47 
4 
63 
46 
25 
33 
32 
65 
6 
 
 
3.4.2 Knowledge scores 
 
Sixty-four (89%) of the survey respondents completed the knowledge section of the questionnaire: 28 (44%) 
from the private sector, and 36 (56%) from the state sector.  Similarly, for the profession subgroups, 28 (44%) 
doctors and 36 (56%) dietitians answered this section and were included in the analysis. 
The questionnaire assessed knowledge of the ESPGHAN international guidelines.8  There were 15 questions, 
with one point allocated to each correct answer.  The knowledge scores were reflected as a percentage of 
the total.  Figure 3.11 shows frequency of correct answers for the knowledge scores for each individual 
questions.   
The respondents only achieved the baseline competency of 80% for five of the questions.  The highest scores 
related to the practicalities of PN usage (hanging time of the bag, dedicated line access and filter usage), as 
well as the link between hyperglycaemia and mortality risk, and the inclusion of lipids in PN infusions to avoid 
EFA deficiency.  All the respondents knew that PN should hang for 24 hours.  Interestingly, the two lowest 
correct scores were related to knowledge of patient-specific requirements.  Less than half of the respondents 
(n = 27, 42%) knew the correct range of protein (amino acids) per kilogram body weight to use when 
calculating their PN prescription, while only 53% (n = 34) knew the recommended patient-specific energy 
ranges.  Knowledge of the importance of micronutrients in the PN infusion (the recommendation to include 
both fat-soluble vitamins and trace elements daily) was also below baseline competency.  Only 70% (n = 45) 
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of the survey respondents knew to gradually increase the fluid volume of the PN infusion over time.  With 
regard to the cause of liver steatosis in PN-fed patients, 38% (n = 24) incorrectly thought that the IVLE was 
the primary cause, as opposed to the glucose.                 
 
 
FIGURE 3.11 STUDY RESPONDENT KNOWLEDGE SCORES PER QUESTION 
PN: Parenteral Nutrition; h: hours; IV: Intravenous; IVLE: Intravenous Lipid Emulsion; CLD: Chronic Lung Disease; EFA: Essential Fatty 
Acid 
80% considered baseline competency for knowledge score 
 
The mean knowledge score for the study respondents was 74% (SD ± 12), range 50 – 100%.  Comparison of 
the mean scores for the state and private sector showed no significant difference between the two subgroups 
(73 ± 13% for state versus 76 ± 12 % for private; p = 0.32).  The mean knowledge score for the dietitians (77 
± 13%) was however significantly higher than that of the doctors (71 ± 11%); (p = 0.04) as shown in Figure 
3.12. 
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6ProfessionGroup; LS Means
Current effect: F(1, 62)=3.6282, p=0.06 Mann-Whitney U p=0.04
Effective hypothesis decomposition
Vertical bars denote 0.95 confidence intervals
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FIGURE 3.12 COMPARISON OF THE MEAN PRACTICE SCORES BY PROFESSIONAL SUBGROUP 
 
The study respondents that utilised published guidelines as one of their sources of information achieved 
significantly higher knowledge scores versus those that did not access published guidelines as an information 
source at all (77 ± 2% for published guidelines accessed versus 70 ± 13% for published guidelines not 
accessed; p = 0.04).  Similar to practice scores, a weak negative  association between the number of years of 
clinical experience and the knowledge scores of the study respondents was found (r = - 0.06; p = 0.66).   
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4. Discussion  
 
4.1 Purpose and objectives of the research 
 
Nutrition plays an important role in achieving good clinical outcomes, as well as optimal growth and 
development in this vulnerable patient group.1,3,5,20  PN therapy is often required to achieve feeding goals, 
when EN is insufficient or contraindicated.8,9  In spite of this, the nutritional management of neonatal and 
paediatric patients is highly variable, and knowledge and access to available guidelines do not always 
translate into clinical practice.10,12,87,88  This study was the first in South Africa to examine the prescribing 
practices and knowledge with regard to PN nutrition therapy in neonatal and paediatric patients.  Previous 
questionnaire-based studies for this patient group in South Africa have focused on EN feeding practices.85,92  
This research set out to investigate the current approaches to PN feeding of neonatal and paediatric patients 
in the South African hospital context.  It aimed to examine prescribing practices and the potential factors that 
could influence nutrition decisions.  It also aimed to consider where dietitians and paediatric doctors working 
in this field access information on PN, and to gauge their knowledge of the standardised recommendations 
in the ESPGHAN PN Guidelines.8           
The healthcare structure in South Africa is divided into two main sectors.  The state sector is government 
funded, and services the majority of the population.  The private sector however predominates in terms of 
both funding and staff resources, despite servicing a much smaller percentage of the population.96  It was 
hypothesised that despite the notable difference in context between both sectors, there would not be a 
difference in the clinical practice approaches and knowledge outcomes between the two subgroups. 
For the purposes of this research, it was beneficial to target the healthcare professionals known to work 
actively with the prescription of PN in neonatal and paediatric patients.  In South Africa, the paediatric 
doctors, which include paediatricians, as well as paediatric specialists, are registered to prescribe PN.  
Dietitians are also trained in this field, and as per registration with the Health Professions Council of South 
Africa (HPCSA), can make recommendations on the scripting of PN to neonatal, paediatric and adult patients, 
but owing to the Schedule 3 registration status of the product, may not prescribe in the absence of a doctor.97   
In the context of these different roles, it seemed worthwhile to compare the practice and knowledge 
outcomes between the professional subgroups.  It was hypothesised that there would be no difference 
between the healthcare professionals in terms of their PN feeding practices and knowledge of the guidelines. 
 
Stellenbosch University  https://scholar.sun.ac.za
 62 
 
4.2 Demographic characteristics 
   
The final response rate for this questionnaire was comparable with that of previous South African survey-
based studies related to feeding practices in this patient group.85,92  International studies in this field have 
achieved response rates of between 23 and 100%.10 
There are nine provinces in South Africa.  These vary in terms of population density and economic stability, 
and consequently hospital infrastructure.  Gauteng is the economic and political hub and as such is the most 
densely populated with the largest number of hospitals, both large state academic institutions and private 
facilities.  KwaZulu-Natal is one of the bigger provinces, and therefore has a large number of smaller state 
and private facilities distributed throughout.  The Western Cape has a relatively stable economic climate and 
is the third largest province in terms of hospital infrastructure.98  The survey respondents were based 
predominantly in these three provinces.  There was no representation from Limpopo and the Northern Cape.  
Although this does raise the concern of under-representation, the overall responses stratified by province 
are relatively in line with the distribution of hospitals, as well as neonatal and paediatric PN use in South 
Africa.84,99   
The state and private hospital sector subgroups were both well represented in this study (53% and 47% 
respectively), and allowed for comparison in the analytical component of the study.  There were slightly more 
dietitians (58%) than paediatric doctors (42%) represented in the sample population.  Within the doctors 
group, there was varied representation of the specialties – the majority were paediatricians (63%), but also 
paediatric intensivists (23%), two neonatologists (7%), one paediatric pulmonologist (3%) and a paediatric 
registrar (3%).  Unfortunately, there were no paediatric surgeons or cardiologists.  Previous survey-based 
research investigating PN practices in neonates has focused on the doctors.10  Only one study, based in North 
America, included dietitians in their respondent group.72  Within the South African context, Bradfield (2016) 
is the only similar study in its target of both doctors and dietitians regarding their feeding practices in this 
patient group.  As mentioned previously, the focus of this survey was, however, on EN feeding.92     
The majority of the respondents (86%) indicated that there were more than 6 beds in their unit.  This is 
consistent with the study setting for previous research conducted on neonatal feeding in South Africa –Raban 
et al. (2013) found most respondents were based in a medium-sized (6–10 bed) unit.85  This does also seem 
to be consistent with the European-based surveys.12  
The experience levels of the respondents were relatively well distributed.  The majority had worked in the 
field for between 3 and 20 years (78%).  Four (6%) had more than 20 years of clinical experience.  There was 
a weak negative correlation between the years of experience and the practice and knowledge outcomes.  
This could be indicative of the more experienced paediatric doctors and dietitians not adjusting their 
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practices over time, or keeping up to date with changes in the guidelines.  They perhaps rely more on their 
practical clinical experience to guide their prescription and patient-management decisions.  Practitioners 
who qualified more than 20 years ago would also potentially have had less exposure to PN during their 
training.  None of the previous studies has investigated the years of experience in relation to prescription 
factors and outcomes.    
 
4.3 Parenteral nutrition feeding practices 
 
4.3.1 Parenteral nutrition usage 
 
PN is indicated for the provision of nutrients to neonatal and paediatric patients when it is not possible to 
feed adequately, or at all, into the gastrointestinal tract.1–4  When asked to indicate the main reasons for PN 
usage in their patients, the most common indications were gut anomalies and intolerances, and prematurity, 
which is consistent with current recommendations in the literature.  Gut failure includes SBS, NEC, intestinal 
obstruction, and malabsorption syndromes, and is a clear indication for commencing PN feeding.8,9  The use 
of PN feeding in prematurity is also well documented as a means of maintaining growth trajectories and 
improving long-term neurodevelopmental outcomes in this patient group.3,5,20,29  Malnutrition was also 
indicated as a reason for PN usage.  South Africa has a high prevalence of paediatric malnutrition due to poor 
socioeconomic circumstances and poor household food security.100  The use of PN therapy in this diagnosis, 
although not common practice in the literature, is therefore not surprising in the South African context.  
Oncology and burns are relatively specialised fields, and as such, the lower incidence of use in these types of 
patients is to be expected.  Unfortunately, the survey respondents that indicated ‘other reasons’ for PN use, 
did not elaborate.  It would be interesting to explore what other reasons the prescribers feel are necessary 
indications for the use of PN therapy in their patients. 
This study was unique in its focus on PN therapy for both the neonatal and paediatric patient groups.  The 
majority of survey-based research in this field to date, both in South Africa and abroad, has focused on 
neonatal and particularly premature patient feeding.10–12,85,92  The emphasis on this patient group could in 
part be due to the more definitive feeding guidelines available for premature and neonatal patients, as well 
as related to the higher prevalence of these patients admitted to neonatal and paediatric ICUs.4,8,27–30,34,101–
103  Kruger (2014) investigated the admissions in a paediatric ICU setting in South Africa, and found that the 
majority of patients were under the age of 1 year.  Within this group, most of the patients were premature 
infants and neonates.104  With this in mind, as well as NEC and prematurity being common indications for PN 
feeding, it does make sense that neonatal PN use was slightly higher than paediatric prescriptions in our 
study findings.9,29   
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More than half the survey respondents were only involved in PN prescription once a week.  This might be 
due to EN remaining the preferred method of nutritional support for all premature infants and paediatric 
patients.  PN is often considered an effective yet invasive but relatively expensive intervention, and as such 
is usually a secondary choice to commencing with enteral feeding.1,3,4,7  The relatively low frequency of PN 
usage could also relate to the various factors attributed to the delay or non-use of PN feeding when it is 
indicated.    
 
4.3.2 Calculation of parenteral nutrition requirements 
 
ESPGHAN’s Guidelines for Paediatric Parenteral Nutrition is an extensive document that has dedicated 
chapters for each nutrient, discussing the evidence base for its inclusion in PN therapy, but also providing 
recommendations on how to calculate requirements on a patient-specific basis.8  Of particular relevance to 
PN feeding in neonatal and paediatric patients is the calculation of energy (TE), the glucose oxidation rate, 
amino acid (protein) requirements, and the fluid allowance.8,9,26,29,30 The study survey investigated the 
frequency with which the respondents were likely to calculate these parameters for their patients.  The 
paediatric doctors definitely prioritised fluid calculation and were less likely than the dietitians to consider 
the energy and protein calculations.  Perhaps the most noteworthy finding in this regard was the difference 
in protein calculation between the two professional subgroups.  The dietitians were significantly more likely 
to calculate patient-specific amino acid requirements than the paediatric doctors (p < 0.001).  Bradfield et al. 
(2016) found that this was also the case for EN feeding protein calculation.92  None of the other studies in 
this field examined the calculation of requirements.  Their focus was more on nutrient targets and 
achievement of these goals in patient feeding.10,12,72 
 
4.3.3 Timing of parenteral nutrition commencement and lipid introduction     
 
The focus in the guidelines for the timing of PN commencement tends to be on the provision of amino acids. 
In premature infants in particular, recommendations are that PN feeding be started almost immediately after 
birth, or at least within the first 2 – 6 hours.3  ESPGHAN recommends starting with protein supply on the first 
postnatal day.8  In older paediatric patients, the guidelines are less clear.  The results from the PEPaNIC trial 
implied that commencement of PN should be delayed for the first week, but this does not take individual 
diagnosis or nutritional status of the patient into account.35  As with adults, the recommendation stands that 
when EN therapy is contraindicated or inadequate, if the child is malnourished or considered at high 
nutritional risk, or has a diagnosis associated with high nutrient demands, PN feeding should commence on 
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day 1.23,25  Our results showed that only 36% of the survey respondents commenced PN feeding within the 
first 24 hours.  The majority (49%) started on day 2.  This finding is consistent with a chart review conducted 
by Turpin et al. (2013) – only one-third of the preterm patients received amino acids within day 1.87  A review 
by Lapillone et al. (2013) also indicated that PN initiation on day 1 was between 24 and 54%, and that most 
prescribers (67–94%) started PN by day 2.10  Their multicentre European-based survey conducted in the same 
year did however indicate a more optimal practice – 63% of the doctors aimed to commence amino acids 
within the postnatal day.12  Hans et al. (2014) also found that the majority of healthcare professionals started 
PN therapy within the first 24 hours in very preterm patients.72  In the older paediatric patients, starting early 
with PN is far less likely.  Fivez et al. (2016) favoured day 7, which was the same as one respondent in our 
study.35  Moreno et al. (2016) noted that only 10% of paediatric patients received PN therapy within the first 
day.13   
The timing of PN commencement was one of the areas in which the respondents scored the lowest on the 
practice score assessment.  Interestingly, there was a significant correlation between achieving an optimal 
best practice score and the timing of PN initiation.  Those dietitians and paediatric doctors that started 
feeding early, seemed to have more optimal overall clinical practices in terms of their PN feeding approach. 
The use and timing of IVLE is possibly one of the most researched aspects of PN therapy in neonates and 
paediatric patients.  There still appears to be controversy in terms of the timing of IVLE, as well as the reasons 
for stopping, delaying, and avoiding IVLE administration.4,8,26–30,40  The ESPGHAN Guidelines recommend 
commencement of lipid within the first 3 days in newborn infants receiving insufficient EN feeding, and note 
that it is safe to commence from day 1.  The guidelines in paediatrics are less definitive, but minimum 
provision in all patients is recommended to avoid an EFA deficiency.8  This was an area of practice in which 
the survey respondents actually did quite well compared with findings in previous studies.  Two-thirds (67%) 
included IVLE from day 1.  A review of various practice-related surveys showed that 46 – 96% of healthcare 
professionals introduced lipids before day 3.10  In a French-based study, more than half of the prescribers 
only commenced with IVLE after day 3.11  Turpin et al. (2013) noted that only 34% of patients were receiving 
IVLE as part of their PN by day 3.87  In the survey examining practices across European neonatal units, 
Lapillone et al. (2013) found excellent compliance with the ESPGHAN Guidelines in this regard – 90% of their 
physicians aimed to initiate lipid within the first 3 days of PN feeding.12        
The 24 (33%) respondents that did delay IVLE introduction to their PN prescription were asked to elaborate 
on their reasons for this clinical practice decision.  It was quite alarming that the predominant reason given 
was habit.  This has not been noted in previous studies.  The finding alludes to the honesty of the respondents, 
but also highlights that sometimes feeding decisions are made based on a preference or routine, rather than 
on evidence-based practice.  Six (25%) of the respondents highlighted liver function concerns as their 
reasoning for IVLE delay.  This is consistent with previous study findings as a common reason for clinicians to 
stop or decrease IVLE infusion.10  Four (17%) of the respondents stated PN bag availability as their main 
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reason.  Interestingly, these responses were split between the private and state hospital settings, and were 
also not based in the more remote provincial regions. This finding could therefore be interpreted as having 
less to do with access to PN bags containing lipid, and perhaps more to do with a need for different lipid-
containing formulations.  This would need to be explored further in future research.  Other reasons given 
included metabolic acidosis, respiratory function, and line-tissuing concerns.  Our findings are consistent with 
the literature, which in addition to the reasons we found, also included confirmed or suspected sepsis, low 
platelet count and elevated triglycerides as reasons for stopping or decreasing the IVLE dose.10,11,72,88  One 
respondent who selected ‘other’ did not elaborate – perhaps his/her reasoning was in line with one of these 
additional noted concerns.      
 
4.3.4 Practice scores 
 
In line with the study objectives, the practice score outcomes gave some indication of how well the 
healthcare professionals are doing in their adherence to the guidelines and recommendations for PN feeding 
in their neonatal and paediatric patients.  Our finding of a mean practice score of 74% is consistent with 
findings in previous studies.  Although these studies did not assess clinical practice in exactly the same way, 
they have all highlighted that implementation of recommended guidelines in clinical practice is not being 
readily and optimally achieved.11–13,72,87   
The respondent group met the set baseline competency level for fluid and protein calculation, as well as the 
timing of IVLE initiation.  The initiation of PN within the first 24 hours and calculation of the patient-specific 
glucose oxidation rate were notably suboptimal.  There was no significant difference in clinical practice 
between the private and state sector subgroups.  This finding is consistent with the EN feeding survey 
conducted by Raban et al. (2013).  The comparison between the profession subgroups, however, yielded a 
thought-provoking outcome.  The dietitians achieved a significantly higher mean practice score than the 
paediatric doctors.  As so few studies have looked at dietitians in relation to PN feeding practices to date, this 
is a unique and interesting finding.  In the South African context, where dietitians are not allowed to prescribe 
PN due to its Schedule 3 status, but rather make recommendations on the prescription in conjunction with 
the doctor, it is noteworthy that their adherence to the guidelines is more optimal in clinical practice.97   
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4.4 Factors affecting parenteral nutrition usage            
 
In line with Objective (ii) of the study, the survey respondents were asked to indicate the potential factors 
that influence their decision to delay or avoid PN therapy for their neonatal or paediatric patients.  The most 
common reason given was concern regarding the risk of infectious complications.  Fivez et al. (2016) 
highlighted the benefit of delaying PN feeding in paediatric patients for the first week, particularly in terms 
of infection-related outcomes.35  The high nutrient content of PN does provide an ideal medium for bacterial 
and fungal growth, so this concern is not unfounded.  Much of this perceived infection risk, however, may be 
unfairly attributed to the PN therapy.  The CVC and line access, as  well as the handling of the PN during 
administration, are the critical factors associated with infection risk.8 Patients receiving PN feeding are usually 
the more critically ill patients, and are therefore more prone to complications overall.  Adult studies have 
shown that in comparison with EN feeding interventions, PN does not necessarily pose a higher infection risk.  
In fact, in some instances the incidence of infections was found to be lower in PN therapy groups.105,106  In 
the South African context, PN is compounded in a single, centralised commercial facility.  This method, in 
comparison with hospital-based compounding, has been shown to help minimise the infection risk associated 
with the actual PN solution by providing a sterile, standardised end product.79  The key message in the 
literature remains that the safe, appropriate administration of PN can minimise infection risk in neonatal and 
paediatric patients.81–83  Our finding, however, indicates that dietitians and paediatric doctors still have 
concerns in this regard. 
PN is often associated with a high cost, and several factors related to this were stated as reasons for delay or 
non-use of PN.  The high cost of PN in comparison with other feeding modalities was another frequent reason 
given.  Interestingly, there is evidence to suggest that central compounding of PN is a more cost-effective 
approach than hospital mixing.79  Our findings do however highlight that the perception of high cost may be 
enough to influence PN feeding practices.  A small number of the respondents (11%) also listed budget 
limitations in their institutions as a primary reason for avoiding PN therapy for their patients.  Not 
surprisingly, the majority of the respondents who highlighted this as a main issue, were based in state 
facilities.  The budget limitations in the public health sector are well documented in the literature, and are a 
concern for overall healthcare provision and medical care in state hospitals.84,96,99  Eleven (15%) of the private-
based doctors and dietitians stated that medical aid limitations influenced the use of PN for their patients.  It 
is interesting that regardless of the work sector setting, the cost of PN was a relevant factor in determining 
feeding decisions for this patient group.  Healthcare professionals may feel that they cannot compromise on 
costly medical interventions, but that nutrition is an area where they can reduce costs when necessary. 
A lack of access to PN also appears a frequent reason for PN delay or non-use.  This factor could be linked to 
the delivery of PN, as well as ordering restrictions within the facility.  The proximity to PN distribution centres 
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may play a role here.  This is a potential limitation of having only commercially available PN solutions in South 
Africa.  In both the state and private sectors, weekend ordering is sometimes restricted by the availability of 
a hospital pharmacist to process the script.  The state facility access to PN may also be limited by tender 
availability of a product.86,96           
A lack of trained staff to administer the PN to patients was also a concern for the study respondents, and is 
a factor that might negatively impact on PN use, even when it is indicated for patients.  This is not a surprising 
outcome, as PN requires both trained doctors and nurses for its safe and successful administration.  
Placement of a CVC or PICC line requires a competent doctor, and the correct hanging of the PN bag relies 
on nursing staff who are properly trained in aseptic techniques, as well as neonatal and paediatric critical 
care.  The paucity of healthcare professionals, especially doctors and nurses, in the South African health 
sector is well documented in the literature.  Understaffing, combined with an inadequate skill set in the 
existing staff, may certainly influence the willingness of a paediatric doctor or dietitian to commence PN 
therapy for his or her patients.107,108 
A lack of knowledge was noted by nine (13%) of the respondents as a factor that may affect their delay or 
non-use of PN.  There was no significant difference between the knowledge scores of those who perceived 
their inadequate knowledge to be a factor influencing their PN use and those who did not.  Interestingly, 
however, three of the respondents that listed lack of knowledge as a concern, did not complete the 
knowledge assessment component of the questionnaire.  Few studies have assessed knowledge in relation 
to PN prescription.  Ahmed et al. (2004) noted that two-thirds of the doctors they interviewed (specialist 
registrars working in neonatal units) had no idea how much protein to prescribe for their patients, and also 
no knowledge of the amount of nitrogen available in the PN solutions.88  
Finally, a large proportion of the survey respondents (25%) selected ‘other’ as their primary reason for 
avoiding PN feeding.  Unfortunately, none elaborated on their responses.  It would have been really useful 
for the purposes of this study to gain insight into additional factors that may influence the way in which PN 
feeding is implemented in neonatal and paediatric patients.       
These results highlight some interesting factors that influence the use of PN for neonatal and paediatric 
patients in South Africa.  The prescription of PN is not only determined by patient need, but also by clinical 
factors such as infection risk, economic considerations, staff and medical resource availability, overall access 
to the PN solutions, and the prescriber’s knowledge. 
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4.5 Respondent knowledge assessment 
 
The knowledge aspect of this study incorporates two of the study objectives.  The first investigated where 
the survey respondents access the information they use to guide their PN feeding practices, and the second 
consisted of an actual assessment of their knowledge of the ESPGHAN Guidelines.8 
Our findings highlight the use of literature by both the dietitians and the paediatric doctors as the main 
resource used to guide their PN feeding decisions.  Also, those prescribers that accessed the published 
guidelines as a resource achieved a significantly higher knowledge score than those not utilising the 
guidelines at all.  Lapillone et al. (2013) is the only other study to have considered awareness of PN guidelines.  
Their European-based survey noted that 80% of the senior physicians working in neonatal units made use of 
published guidelines – this included the ESPGHAN International Guidelines8, national (country-specific), as 
well as in-house guidelines.  Although they did not conduct a knowledge assessment of the guidelines, they 
noted that awareness of the guidelines did not necessarily translate into clinical practice.12   
The smallest number of respondents (25%) made regular use of journal clubs, ward rounds and internal 
meetings to guide their clinical nutrition practices.  As could be expected, the majority of this group were 
based in the academic and tertiary level state institutions.  The five private hospital-based doctors and 
dietitians were all from Gauteng and the Western Cape.  This suggests that access to this type of forum is 
dictated by the location of the hospital, as well as the teaching focus of the institution. 
The four respondents (6%) that stated other sources of information as their main resource did not elaborate.  
It would have been interesting to gain insight into what other forms of information on PN therapy are 
available and considered important in guiding clinical practice. 
For the knowledge assessment component of the study, it was unfortunate that eight of the participants 
withdrew from the survey at this point, and could not be included in this section of the analysis.  The reasons 
for withdrawal are unknown.  One could speculate that they felt their knowledge was inadequate, but it 
could also have been survey fatigue or some other reason.   
The mean knowledge score for the group was suboptimal, and only 5 of the 15 questions in the knowledge 
section achieved a correct score above the baseline competency of 80%.  The questionnaire did not 
specifically ask the respondents if they are aware of the ESPGHAN guidelines.  The knowledge component of 
the questionnaire was also developed based predominantly on expert opinion as no previous validated 
questionnaire was available.  These two factors could have contributed to the suboptimal knowledge scores.   
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In spite of these potential limitations, our findings highlight that healthcare professionals may lack knowledge 
of the patient-specific PN nutrient requirements, the recommended content of the PN solutions, and even 
the practicalities of increasing feeding volumes and line access routes in their patients.  There was also a 
deficiency in knowledge regarding the causes of some of the potential clinical complications associated with 
PN feeding.   
It is of concern that the prescribers scored poorly on the patient-specific requirement questions.  This finding 
suggests that although dietitians and paediatric doctors may claim to be calculating the nutrient needs of 
their patients, these calculations are either based on the incorrect values, or they are not actually doing the 
calculations in daily practice.  Our finding that less than half the respondents knew the correct amino acid 
range is consistent with that of Ahmed et al. (2004) – two-thirds of the doctors they interviewed did not know 
the protein requirements of their patients or the amino acid content of the PN solutions they were 
administering.88   
It is encouraging that the practical aspects of PN usage were well known by most of the respondents.  All the 
participants knew the correct hanging time of 24 hours.  Most knew about the importance of dedicated line 
access, as well as the use of a filter to administer the PN to the patient.  The correct handling of PN solutions 
is known to minimise the infectious complication risk, and filter usage prevents the occurrence of a fat 
embolus.8,9      
As with the practice score outcomes, the dietitians performed significantly better than the paediatric doctors 
in their knowledge scores.  This finding again emphasises that although dietitians are currently only involved 
in an advisory capacity regarding PN prescription, they have a sound knowledge base and training in this field.      
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5.  Conclusion and Recommendations 
 
5.1 Conclusion 
 
Our study provided insight into the use of PN therapy in neonatal and paediatric patients in South Africa.  
Neonatal and paediatric patients are a vulnerable patient group, and their nutritional needs should be 
carefully considered and achieved to maintain both growth and optimal clinical outcomes. Despite clear 
guidelines, particularly in the neonatal group, PN feeding was seldom initiated within the first 24 hours of 
admission.  The inclusion of IVLE in PN prescriptions was relatively well accepted and implemented, but it 
was of concern that the predominant reason for delay of lipid was attributed to habit.  The calculation of 
patient-specific requirements, as well as knowledge of what these requirements are, was also suboptimal. 
Our findings also highlighted the complexity of adhering to optimal PN feeding practices in the South African 
healthcare environment.  Concerns relating to infectious complications, the perceived high cost of 
commercially prepared PN solutions, as well as limited financial and human resources, all influenced 
clinicians’ decisions to implement PN therapy for their patient. 
Also, access to information did not necessarily translate into ‘best practice’ and sound knowledge of the PN 
guidelines.  The need for updated, concise, well-defined PN feeding recommendations for neonatal and 
paediatric patients is evident.  The necessity of ongoing education and training on PN feeding is also 
fundamental to improving clinical practice and knowledge in this regard. 
In South Africa, the dietitian’s current role in PN prescription is limited to an advisory service.  In our study 
the dietitians performed significantly better than the paediatric doctors in both the practice and knowledge 
assessments.  Our findings emphasise the role of the dietitian as part of the multidisciplinary team in 
achieving optimal feeding. 
In conclusion, PN prescribing practices in South Africa for neonatal and paediatric patients are not yet optimal 
in many respects.  Dietitians and paediatric doctors require access to clear PN therapy guidelines, as well as 
guidance on how to implement these recommendations effectively in daily clinical practice.  A 
multidisciplinary approach to PN feeding is paramount.   Additional research is warranted to further assess 
the PN feeding practices in this vulnerable patient group.   
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5.2 Subgroup analysis comparison outcomes 
 
Based on the study findings, we accept the null hypothesis (H0) that there is no difference in the prescribing 
practices and knowledge of international guidelines between the work sector subgroups (state and private).  
Considering the dietitians scored significantly higher for both the practice and knowledge score assessments 
in the questionnaire, we can however reject the null hypothesis (H0L) for the professional subgroup 
comparison.    
 
5.3 Strengths and limitations 
 
This is the first study of its kind in South Africa to investigate the PN prescribing practices in neonatal and 
paediatric patients.  This study is also unique in its assessment of the prescriber knowledge of the 
international PN feeding guidelines and recommendations, as well as in comparing the different hospital 
sectors (state and private) and professional groups (paediatric doctors and dietitians) within this context.  
There were limitations to the current study.  Questionnaire-based surveys are challenging in terms of 
achieving an optimal response rate.  One of the major limitations of our study was the low participation rate.  
Although a targeting sampling process was conducted, there is no database available in South Africa to 
determine which paediatric doctors and dietitians specifically work with PN, and would therefore have met 
the inclusion criteria.  We relied on the relevant associations to guide us in targeting the survey respondents.  
The subgroup analyses were also limited by the relatively small sample size.  For particular analyses where a 
notable difference in the guidelines exists, it would also have been beneficial to further separate the groups 
into paediatric and neonatal groups had the respondent numbers allowed. 
The absence of respondents from Limpopo and the Northern Cape also raises concerns regarding under-
representation.  Responses from Limpopo and the Northern Cape would potentially have been useful, as 
these two provinces are based relatively far from the established PN distribution centres, and also are 
considered comparatively resource poor, and could therefore potentially have had a slightly different PN 
usage pattern as well as different factors influencing clinical practice. This is, however, speculation and would 
need to be explored through additional research. 
There were slightly more dietitians than paediatric doctors who participated in the study.  The concern of 
under-representation could also be related to the absence of some paediatric specialties responding to the 
survey.  There were no paediatric surgeons or paediatric cardiologists in the sample.   
As the questionnaires were self-administered, the study design relied on the honesty and transparency of 
the respondents.  Although a pilot and validation process was conducted to minimise ambiguity, 
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misinterpretation of a question could have influenced the responses.  Unfortunately, for those questions 
with an option for ‘other’, the respondents did not elaborate further.  This limited the ability of the research 
team to fully interpret the responses in some cases.  For the section on factors influencing PN usage 
especially, it would have been useful to gain insight into additional issues the respondents felt affected their 
PN prescription practices. 
The information access section of the questionnaire was also quite limited and could possibly have explored 
the presence of unit protocols and how these related to PN prescription and the guidelines. 
The practice score was composed of quite a limited range of prescription-related questions.  It would have 
been useful to explore clinical practice in more detail, perhaps also incorporating the choice of line access 
(central versus peripheral, as well as the use of umbilical lines in neonates); monitoring practices (such as 
frequency of blood glucose and electrolyte monitoring, LFT and serum triglyceride testing, utilisation of 
urinary glucose and anthropometrical measurements); as well as the use of insulin therapy in relation to PN 
feeding.   
Finally, the knowledge score could have been impacted by the choice of questions selected to assess the 
respondent knowledge of the ESPGHAN guidelines. 
 
 5.4 Recommendations 
   
In terms of answering the research question, it would be beneficial to conduct additional survey-based 
research with a larger sample size and more equal representation in the subgroups.  This would enable 
further analyses, and perhaps additional statistical inferences could be achieved. 
A multicentre chart review to analyse the actual feeding practices in relation to the guidelines in neonatal 
and paediatric patients is also recommended in order to gain further insight into prescribing practices and 
adherence to guidelines and protocols. 
Further research could be extended to include nursing staff and investigate their role and practices in terms 
of neonatal and paediatric PN usage in South Africa.   
South Africa is relatively unique in the way in which PN feeding is conducted, and it would be useful to explore 
how other African countries, and their prescribers, are faring in terms of both their knowledge and practices, 
as well as access to PN for their patients. 
The ESPGHAN Guidelines are relatively outdated, and new guidelines are due for publication shortly.  It is 
recommended, post publication of the new guidelines, to assess if there are changes, and perhaps 
improvements, in both clinical practice and knowledge outcomes.   
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Finally, if additional PN products, such as SMOFlipid®, were to become readily available in the South African 
context, it would be useful to investigate prescribers’ experiences and use of lipid in neonatal and paediatric 
patients further.  Adequately powered, randomised clinical trials researching the use of a new lipid in relation 
to clinical outcomes in this patient group are also recommended. 
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PARTICIPANT NUMBER  
 
 
Neonatal and paediatric parenteral nutrition prescription 
practices in South Africa: a cross-sectional survey 
 
 
Thank you for agreeing to participate in this research study. 
 
Instructions: 
 Please answer the questions honestly. Remember your identity is kept completely 
confidential. 
 If you are unsure of the meaning of any question, you may ask the researcher for assistance. 
 Please tick the most relevant box. 
 
Demographic and Background Information: 
1. Please indicate which province you are currently working in: 
 Tick (√) 
A Eastern Cape  
B Free State  
C Gauteng  
D KwaZulu-Natal  
E Limpopo  
F Mpumalanga  
G Northern Cape  
H North-West  
I Western Cape  
 
2. I currently work and prescribe parenteral nutrition at: 
 Tick (√) 
A State – regional / secondary hospital level  
B State – academic / tertiary hospital level  
C Private  
D Both – but predominantly private  
E Both – but predominantly state  
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3. I am qualified as (please indicate the highest qualification): 
 Tick (√) 
A Neonatologist  
B Paediatric pulmonologist  
C Paediatric surgeon  
D Paediatric cardiologist  
E Paediatrician  
F Medical Officer  
G Dietitian  
H Other … please specify 
 
___________________________________________ 
 
 
 
4. I have been actively practising and prescribing in the field of neonatal / paediatric medicine or 
nutrition for: 
 Tick (√) 
A 0 – 2 years  
B 3 – 5 years  
C 6 – 10 years  
D 11 – 20 years  
E > 20 years  
 
Prescribing Practices:   
If you work in both the private and state sectors, please answer the following questions for the 
unit in which you do most of your parenteral nutrition prescribing. 
5. The unit/s in which I prescribe parenteral nutrition in neonatal and/or paediatric patients has a 
total of: 
 Tick (√) 
A 1 – 5 beds  
B 6 – 10 beds  
C > 10 beds  
 
6. I currently prescribe parenteral nutrition in neonatal patients: 
 Tick (√) 
A Yes  
B No  
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7. If yes, please indicate how often you prescribe parenteral nutrition in this patient group 
(please select the most correct answer from the list below): 
 Tick (√) 
A Daily  
B 2 – 3 times per week  
C Once a week  
 
8. I currently prescribe parenteral nutrition in paediatric patients: 
 Tick (√) 
A Yes  
B No  
 
9. If yes, please indicate how often you prescribe parenteral nutrition in this patient group 
(please select the most correct answer from the list below): 
 Tick (√) 
A Daily  
B 2 – 3 times per week  
C Once a week  
 
10. The main reason I use parenteral nutrition in my neonatal / paediatric patients is for the 
following conditions:   
Please rank your answer in order of predominant usage, with 1 being the main reason, etc.  If 
not applicable to your prescription of parenteral nutrition, please leave the block next to that 
option blank. 
 
 Tick (√) 
A Prematurity  
B Gut anomalies or intolerances  
C Post-operatively  
D Oncology  
E Burns  
F Malnutrition  
G Critically ill patients  
H Other … please specify 
 
___________________________________________ 
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11. In my patients, where it is clear that enteral feeds will not be tolerated or possible, I start 
parenteral nutrition: 
 Tick (√) 
A Within < 24 hours (day 1)  
B Within 24 – 48 hours (day 2)  
C Within 49 – 72 hours (day 3)  
D If later, please specify 
 
By day ______________________ 
 
 
 
12. In my patients requiring parenteral nutrition, I introduce lipid (fat) to the prescription from: 
 
 Tick (√) 
A Day 1  
B Day 2  
C Day 3  
D After day 3  
 
13. If you answered B, C or D for question 12, and do not use lipid (fat) containing parenteral 
nutrition in your patients from the initiation of parenteral nutrition (i.e. day 1), is it 
predominantly due to (please select one answer): 
 Tick (√) 
A Parenteral nutrition bag availability  
B Concerns regarding respiratory function  
C Concerns regarding tissuing of the line  
D Concerns regarding liver function  
E Habit of administering clear (fat-free) TPN initially  
F Concerns regarding metabolic acidosis  
G Other … please specify 
 
___________________________________________ 
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14. When prescribing parenteral nutrition in my patients, the prescription (dosage and rate) is 
mainly based on (please only select one answer): 
 Tick (√) 
A The fluid allocation for my patient  
B The protein requirements for my patient  
C The energy requirements for my patient  
D The volume size of the parenteral nutrition bag  
E The parenteral nutrition code I am most familiar with  
F Other … please specify 
 
___________________________________________ 
 
 
 
15. When prescribing parenteral nutrition, I calculate patient-specific energy requirements? 
 Tick (√) 
A Always  
B Never  
C Sometimes  
  
16. When prescribing parenteral nutrition, I calculate and consider the glucose oxidation rate of 
my patient? 
 Tick (√) 
A Always  
B Never  
C Sometimes  
 
 
17. When prescribing parenteral nutrition, I calculate patient-specific protein requirements? 
 Tick (√) 
A Always  
B Never  
C Sometimes  
 
18. When prescribing parenteral nutrition, I calculate patient-specific fluid requirements? 
 Tick (√) 
A Always  
B Never  
C Sometimes  
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Factors Influencing Prescription: 
19. The main reason I do not prescribe parenteral nutrition, or may delay prescribing PN in my 
neonatal / paediatric patients when it is indicated, is due to:  
Please rank your answer in order of the most predominant reason, with 1 being the main 
reason, etc.  If not applicable to your setting or situation, please leave the block blank. 
 Tick (√) 
A My concerns about the high cost of parenteral 
nutrition  
 
B Budget restrictions in my institution  
C Concerns regarding the infectious complications 
associated with parenteral nutrition 
 
D A lack of trained staff to administer PN  
E A lack of access to parenteral nutrition (delayed 
ordering and delivery) 
 
F Inadequate knowledge  
G Medical aid limitations  
H Other … please specify 
 
___________________________________________ 
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Knowledge of Guidelines: 
20. I get most of my information on parenteral nutrition from:  
Please rank your answers in order of the most relevant reason, with 1 being the main source of 
information, etc.  If not applicable as a source of information for you, please leave the block 
blank. 
 
 Tick (√) 
A Journal articles  
B Congress and conference lectures  
C Journal clubs, ward rounds and internal meetings  
D Company representatives  
E Lecture notes from my studies  
F Published guidelines  
G Other … please specify 
 
___________________________________________ 
 
 
 
21. According to the international guidelines on parenteral nutrition in paediatric patients, an 
infant (0–1 year), but not preterm, on parenteral nutrition requires: 
 
 Tick (√) 
A 30 – 60 kcal/kg/day  
B 60 – 75 kcal/kg/day  
C 75 – 90 kcal/kg/day  
D 90 – 100 kcal/kg/day  
E 110 – 120 kcal/kg/day  
F I do not know  
 
22. According to the international guidelines on parenteral nutrition in paediatric patients, a 
minimum of __________ and maximum of  ____________ amino acid intake is recommended: 
 
 Tick (√) 
A 1 g/kg/day; 5 g/kg/day  
B 1.5 g/kg/day; 4 g/kg/day  
C 0.5 g/kg/day; 2.5 g/kg/day  
D 2 g/kg/day; 3 g/kg/day  
E I do not know  
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23. Patients who do not receive lipid as part of the parenteral nutrition prescription are at risk of 
developing an essential fatty acid deficiency. 
 Tick (√) 
A True  
B False  
 
24. Early administration of intravenous lipids in the first days of life increases the incidence of 
chronic lung disease or death in premature infants when compared with late administration of 
intravenous lipids. 
 Tick (√) 
A True  
B False  
 
25. Feeding a patient high amounts of lipid (fat) in parenteral nutrition is the primary cause of liver 
steatosis (“fatty liver”). 
 Tick (√) 
A True  
B False  
 
26.  Hyperglycaemia (elevated blood glucose levels) is associated with increased infectious-related 
mortality. 
 Tick (√) 
A True  
B False  
 
27. Parenteral nutrition infusions are light sensitive and should be protected during phototherapy. 
 Tick (√) 
A True  
B False  
 
28. A gradual increase of fluid volume when administering parenteral nutrition in neonatal and 
paediatric patients is not necessary. 
 Tick (√) 
A True  
B False  
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29. Please select the correct answer to complete the following statement:  Expected weight gain in 
preterm and term infants is __________ body weight per day. 
 Tick (√) 
A 2 – 5 g/kg  
B 8 – 12 g/kg  
C 10 – 20 g/kg  
D 25 – 30 g/kg  
 
30. Parenterally fed infants and children should receive an intravenous supply of trace elements 
such as copper and zinc as part of the infusion. 
 Tick (√) 
A True  
B False  
 
31. The fat-soluble vitamins (A, D, E and K) do not need to be included in a parenteral nutrition 
infusion daily. 
 Tick (√) 
A True  
B False  
 
32. In neonates, the umbilical vessels can be used for parenteral nutrition infusion, but the risk of 
complications increases if the umbilical artery catheters are left in place for more than 5 days. 
 Tick (√) 
A True  
B False  
 
33. The catheter port used for parenteral nutrition administration may also be safely used for 
blood sampling and medication administration. 
 Tick (√) 
A True  
B False  
 
34. The use of a terminal filter for the administration of parenteral nutrition in neonatal and 
paediatric patients is not essential. 
 Tick (√) 
A True  
B False  
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35. The parenteral nutrition bag and administration line of lipid-containing infusions should be 
changed after no more than 24 hours in order to minimise infectious complications. 
 Tick (√) 
A True  
B False  
 
 
 
  
 
Thank you for offering your time to participate in this research study! 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
